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ABSTRACT 
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(May 2009) 
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Co-Chairs of Advisory Committee: Dr. Gary L. Williams 
       Dr. Marcel Amstalden 
 
 
 
 In Experiment 1, 12 cyclic mares were assigned randomly to one of two groups (n 
= 6/group): 1) Control, saline; and 2) GnRH, 100 µg/h.  Between 3 and 6 d after 
ovulation (Day 0), Alzet osmotic minipumps (Model 2ML1) containing saline or GnRH 
were placed subcutaneous  and connected to a jugular infusion catheter.  Five-min 
samples were collected from the intercavernous sinus (ICS) of 10/12 mares (5/group) 
during 8 h on Day 4, followed by an additional 6-h intensive sampling period 36 h after 
induced luteal regression (Day 6).  Treatment with GnRH markedly increased (P < 0.01) 
secretion of LH during both luteal and follicular phases.  During the luteal phase, 
treatment with GnRH eliminated the very large, intermittent secretory episodes of LH 
characteristic of controls and produced frequent episodes of LH release of short duration.  
In Experiment 2, 12 anovulatory mares and 3 mares with some residual follicular activity 
(n = 15) were used during the fall (December 5 to 20) and winter (February 15 to 29) 
seasons.  Mares were assigned randomly to: 1) Control, 2) GnRH-20; continuous infusion 
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of GnRH at 20 µg/h, or 3) GnRH-100; continuous infusion of GnRH at 100 µg/h.  
Treatments were administered subcutaneously for 14 d using Alzet minipumps.  Both the 
20- and 100-µg/h treatments increased (P < 0.01) mean circulating concentrations of LH 
compared to controls before the winter solstice, but mares did not respond to the GnRH-
20 dose after the winter solstice.  GnRH-100 caused a seasonally-independent increase (P 
< 0.0001) in follicle size and ovulation frequency compared to controls  The equine 
gonadotrope responded to continuous administration of high-dose GnRH during both 
ovulatory and anovulatory seasons, but was less responsive late compared to early in the 
anovulatory season.
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CHAPTER I 
INTRODUCTION 
 
 The natural equine breeding season in the northern hemisphere is restricted to 
approximately the interval between April and October, with the majority of mares 
becoming anovulatory during the late fall and remaining anovulatory throughout the 
winter [1].  This 5 to 6-mo period of ovarian quiescence creates significant challenges for 
horse breeders involved with the > 40% of breed associations that have adopted January 1 
as the universal birth date for their respective breeds.  
 Previous research has focused on developing a greater understanding of the 
neuroendocrine basis of equine seasonality, including the role of day length [1], pineal 
melatonin [2], and hypothalamic hormone secretion [3], as well as management strategies 
for obviating the effects of season.  The control of photoperiod with artificial lighting is 
one managerial strategy that can be used effectively to hasten the onset of spring 
transition [4,5].  However, this approach is often associated with facility and cost-related 
limitations.   
 The administration of GnRH to induce follicular development and ovulation 
during the anovulatory season has also been investigated.  Both pulsatile [6,7] and 
continuous [8] treatment with GnRH during late winter-early spring have been used with  
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varying success.  Clearly, pulsatile treatment with GnRH is more effective than 
continuous, and a consistent response has been observed following this treatment method 
between the months of January and April.  However, there is evidence that the equine 
gonadotrope is relatively resistant to desensitization by continuous administration of 
native GnRH [9], and continuous infusion of doses ranging from as low as 2 µg/h 
[6,10,11] to as large as 110 g/h have been successful in increasing the secretion of LH in 
mares during both the ovulatory [11] and anovulatory [6] seasons, as well as in 
ovariectomized mares [9].  Therefore, continuous treatment regimens have been explored 
more exhaustively for treating anovulatory mares than pulsatile treatment due to the 
practicality of the former approach.  
 Previous work conducted in this laboratory has shown that treatment of mares 
with low doses of GnRH (2.5-5.0 µg/h) beginning during late September/early October 
and continuing through March did not prevent the development of seasonal anovulation 
[12] or advance the timing of onset of spring ovulation, although the use of similar doses 
after April 1 was successful in approximately 80% of persistently anovulatory mares 
[11].  Therefore, the question remains as to whether the seasonal anovulatory state is 
controlled solely by a limitation of endogenous GnRH secretion, or, alternatively, 
involves changes associated with pituitary responsiveness.  Additional studies in our 
laboratory utilizing the intercavernous sinus (ICS) sampling technique [13], that allows 
the measurement of pulsatile secretion of both GnRH and the gonadotropins, have found 
that GnRH concentrations do not change over the anovulatory season, therefore, resulting 
in the conclusion that GnRH may not be limiting during the anovulatory season.  These 
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findings are contrary to accepted dogma which suggests that the lack of an adequate 
GnRH signal to the anterior pituitary is the primary cause of seasonal anovulation.  
Therefore, additional experiments are required in order to resolve this conflict and to 
more fully understand the unique interrelationships that appear to exist between the 
equine hypothalamus and anterior pituitary.  The two approaches chosen for investigation 
in the current studies were designed to 1) better understand how the concentration 
patterns of ICS LH (gonadotrope response) change in response to continuous GnRH 
infusion during the breeding season, and 2) whether there are discernable changes in 
anterior pituitary responsiveness of anovulatory mares to GnRH before and after the 
winter solstice.  
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CHAPTER II 
LITERATURE REVIEW 
 
2.1 Endocrinology of seasonal reproduction 
2.1.1 Common endocrine features of reproductive seasonality in mammals 
 In seasonal breeders, prolonged exposure to constant photoperiod induces 
photorefractoriness, causing spontaneous reversion in physiology to that of the previous 
photoperiodic state.  In long-day breeders such as rodents, exposure to prolonged short 
photoperiod causes gonadal regression and the development of a winter phenotype; after 
a period of 12-20 weeks the animals progressively recover back to a summer 
physiological state.  This mechanism allows long-day breeders in the natural winter 
environment to reactivate their reproductive axis in anticipation of spring, without the 
requirement for the stimulus of long photoperiod [14].  In the mare as in rodents, a short 
day length is associated with a marked decrease in gonadotropin secretion and 
consequently a decrease in ovarian activity [15].  In short-day breeders such as sheep and 
deer, this same mechanism is also present.  Exposure to a fixed, long-day photoperiod 
causes refractoriness and reversion to a winter-like physiology and, when the photoperiod 
is held constant for a sufficiently long period, these animals express alternating 
transitions in seasonal physiology every 10 to 12 months [16].  
 Even though photoperiod and, consequently, melatonin production seem to have 
the principal roles in circadian rhythm, there are other factors that affect reproduction in 
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seasonal breeders: temperature, nutrition, body condition and ovarian steroids.  In sheep, 
the seasonal changes in the pattern of circulating LH mainly reflect an increase in the 
brain responsiveness to the negative feedback exerted by estradiol during long days on 
the frequency of pulsatile secretion of GnRH and LH [17].  Moreover, the site of action 
of estradiol on the inhibition of LH secretion during anestrus in the ewe has been 
identified.  Gallego-Sanchez and collaborators [18], after treating six different sites in the 
hypothalamus with intracerebral implantation of crystaline estradiol, determined that the 
retrochiasmatic area is the principal site of action of estradiol in the inhibition of LH 
secretion.  On the other hand, treatment of mares with 1 mg of estradiol sc for 15 days 
during the nonbreeding season increases plasma LH concentrations [19].  However, 
during the breeding season, a negative feedback effect of estradiol seems operational and 
is necessary for the decline in LH after ovulation [1]. 
2.1.2 Role of the thyroid gland in seasonal breeding 
Thyroid hormones are essential for the onset of anestrous in a spectrum of 
seasonal breeders.  In sheep it has been demonstrated that the thyroid gland is essential in 
regulating transition into anestrous [20].  
Frequency of LH pulses in thyroidectomized and thyroid-intact ewes is similar 
during the breeding season.  However, circulating LH remained unabated in 
thyroidectomized ewes at the end of the breeding season compared to intact ewes in 
which pulsatile release of LH was inhibited [20].  On the other hand, Thrun and 
collaborators [21] have demonstrated that thyroid hormones are necessary only during a 
limited interval late in the breeding season to promote seasonal reproductive suppression 
in the ewe.  They concluded that there is a critical period of responsiveness during which 
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thyroid hormones must be present for anestrous to develop.  Replacement of thyroxine 
(T4) in thyroidectomized ewes implanted with estradiol during the later stages of the 
anestrous season demonstrated that ewes gradually lose responsiveness to T4 during the 
mid to late anestrous season.  In contrast, the annual prolactin (PRL) cycle was not 
affected by thyroidectomy or T4 replacement, indicating that thyroid hormones are not 
required for all seasonal neuroendocrine cycles [22].  In another study, large doses of 
propylthiouracil (PTU) induced thyroid suppression and consequently appeared to inhibit 
onset of anestrus in the ewe [23].  Viguie et al [24] provided evidence that thyroid 
hormones may act within the brain to promote seasonal inhibition of neuroendocrine 
reproductive function of the ewe.  Concentrations of LH declined in thyroidectomized 
ewes that were treated centrally with thyroxine while peripheral administration of the 
hormone failed to be effective for reducing concentrations of LH [24].  Contrary to the 
ewe, the roles of thyroid hormones in the mare have not been thoroughly investigated. 
Johnson et al [25] showed that thyroid hormones in the mare reach their greatest 
concentration in the circulation during the winter when the mare is typically anestrus. 
However, thyroidectomy failed to alter the onset of anestrus and, compared to ewes, 
thyroid hormones do not seem to play an important role in the control of seasonal 
reproduction in mares [26].  Further research is needed to fully understand the role of the 
thyroid gland in seasonal breeding of this species.  
2.1.3 Hormonal and behavioral characteristics of reproductive seasonality 
 The estrous cycle of the mare averages 21 days and includes a period of 
recruitment of a new follicle wave stimulated by follicle stimulating hormone (FSH), 
followed by deviation, maturation and ovulation, stimulated by LH.  Two or three 
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follicular waves occur during the estrous cycle that are each accompanied by an increase 
on FSH concentrations.  At the end of the last follicular wave, the largest follicle(s), 
denoted as the dominant follicle(s), synthesize and secrete increasing amounts of 
estradiol, reaching a peak approximately 2 days before ovulation.  Follicular-derived 
estradiol is positively correlated with intrafollicular concentrations of inhibin A and 
negatively correlated with FSH [27].  Estradiol induces estrous behavior which, in 
general, lasts 5 to 7 days in mares [28] and is a key factor for generating a full LH surge.  
Estradiol increases LH synthesis, induces GnRH receptors on gonadotrophs and may 
augment GnRH secretion [28]. 
 The corpus hemorrhagicum at the site of ovulation becomes the CL, whose early 
development is regulated by LH.  Progesterone (P4), produced by the CL, starts to 
increase in peripheral circulation soon after ovulation in the mare [29], while in the cow 
and sheep serum progesterone (P4) does not begin to rise until approximately 3 days after 
ovulation [1].  Progesterone is needed in order to maintain pregnancy and also promotes 
alveolar development in the mammary gland [1].  Luteal phase concentrations of P4 
create negative feedback effects on LH [1].  On day 15 to 17 of the estrous cycle, the 
uterus releases PGF2 in a pulsatile manner, associated with  increase oxytocin (OT) 
blood concentrations; the increase in OT secretion is due to estrogen stimulation by the 
growing follicles [30].  This increase in PGF2 causes luteal regression, which results in a 
decline in circulating progesterone concentrations to basal levels if regression is 
complete.  Consequently, the negative feedback effect of P4 on LH is no longer present, 
resulting in a rise in that stimulates final maturation and ovulation of the new dominant 
follicle [1].  
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 The natural breeding season of the mare terminates in October or November and 
is characterized by a failure to develop a follicle or to ovulate a developing large follicle 
[31].  Irvine and collaborators [32] assessed the secretion patterns of FSH in mares during 
the two ovulatory cycles before, and 24 days after, the last ovulation of the season.  They 
also attempted to characterize hormonal profiles and follicular growth patterns with the 
goal of identifying changes that may lead to the termination of follicular growth and the 
breeding season.  One observation was a change in the pattern of FSH release during the 
autumn transition from two surges to one surge per cycle.  Moreover, LH secretion 
decreased  as mares entered the anovulatory period.  In another study [33], no differences 
in plasma concentrations of FSH were observed during the transition into the anovulatory 
season, nor were there any changes observed in the occurrence of the number of large 
follicles or in estrous behavior.  However, concentrations of LH were lower following the 
last ovulation compared to the penultimate ovulation.  Moreover, they also reported that 
some mares continued to show ovarian activity after the last ovulation, exhibiting 
follicular growth and estrous behavior [33].  
The latter portion of the anovulatory season is associated with an increase in the 
number of follicles with a diameter of 15-25 mm and an increase in mitotic index of 
granulose cells [34].  A decrease in FSH concentrations and pulse amplitude has also 
been reported at this time [35] altough, this seems paradoxical since FSH is the hormone 
responsible for the increase in the mitotic index.  For many mares, the ovulatory season is 
preceded by a period of prolonged “estrous-like behavior”, but these mares will often 
reject the stallion [36].  However, serum concentrations of LH do not increase until just 
before the first ovulation of the season [37]. 
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2.1.4 Endogenous patterns of GnRH and gonadotropin secretion 
 The hypothalamic-hypophyseal axis serves as the master control center of 
reproduction in mammals.  Gonadotropin-releasing hormone is the reproductive “master 
hormone” that is released from the hypothalamus and must reach the anterior pituitary 
through the hypophyseal portal vessels to stimulate gonadotropin (LH and FSH) secretion 
[38]. 
Some aspects of equine reproductive endocrinology are unique from that of other 
mammals.  The content of GnRH in the hypothalamus and the quantity of GnRH 
receptors in the anterior pituitary seem not to change during the four seasons [38,39].  
One study that contradicted these findings [40] reported the content of GnRH in the 
hypothalamus to be lower in the median eminence of seasonally anovulatory mares 
during one week before and 12 weeks following the winter solstice.  Content of GnRH in 
the median eminence was increased on the day of the winter solstice.. Based on these 
results, one might conclude that the seasonal restoration of reproductive endocrine 
function in mares occurs more rapidly at the hypothalamic level than at the pituitary or 
ovarian level.  It is well documented that, during the winter anovulatory period, 
circulating concentration of LH are very low and ovarian activity is limited [13,35,38].   
However, one must be cautious in interpreting changes in hypothalamic function based 
on solely on changes in content of GnRH. 
Another aspect of mare reproduction that differs from females of other species is 
that the pre-ovulatory LH surge is prolonged, with serum/plasma concentrations 
increasing gradually from mid-cycle until the day of the peak, approximately one day 
after ovulation [1].  The decrease in secretion of LH after ovulation appears to be driven 
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by ovarian negative feedback effects at the level of the pituitary and not by a down 
regulation of GnRH receptors on the pituitary as is thought to occur in other mammals 
[41].  
Greaves et al. [42] studied the effects of ovarian inputs on GnRH and LH 
secretion immediately post-ovulation in pony mares.  Blood samples were collected from 
the jugular vein and ICS on the day of ovulation and on day 8 post-ovulation in 
ovariectomized mares (OVX within 12 hours of ovulation) and intact mares; GnRH and 
LH concentrations were measured.  Plasma concentrations of LH remained elevated in 
OVX mares, while plasma concentrations of LH declined in intact mares.  There was a 
decline in secretion of GnRH from estrus to day 8, although there was no difference 
between the two groups.  They concluded that the decline in LH requires ovarian 
negative feedback in mares. 
Concentrations of hypothalamic GnRH and pituitary FSH and LH have been 
measured, although these measurements do not provide an assessment of the secretion of 
these hormones.  Moreover, because GnRH is secreted in very low concentrations for 
local effects at the anterior pituitary, and because it is rapidly degraded in the blood, its 
relative mean concentration cannot be measured in peripheral plasma or serum.  
However, different techniques have been developed in an effort to overcome these 
disadvantages.  Sharp and Grubaugh [43] utilized the technique of push-pull perfusion, 
which involves the placement of a concentric cannula into the area of the medial basal 
hypothalamus to perfuse a carrier medium through the tissue to estimate hypothalamic 
GnRH secretion in conscious horses.  Secretory rate was found to increase progressively 
from anestrus to estrus in the breeding season.  However, there was not a temporal 
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agreement between LH and GnRH pulses.  Overall, there were about 65% as many peaks 
of LH identified as there were peaks of GnRH.  Occasionally, a peak of GnRH was seen 
accompanied by a peak of LH.  Therefore, the main objective of this experiment, to 
understand the neuroendocrine mechanism regulating gonadotropin secretion in the mare, 
was not completely achieved with this technique. 
In 1984, Irvine and Hunn [44] developed the intercavernous sinus (ICS) 
cannulation technique for measuring both GnRH and the gonadotropins in the mare.  
Using this approach, the superficial facial vein is cannulated and the tip of the cannula is 
threaded into the ICS where venous effluent from the pituitary can be collected.  This 
technique allows the collection of blood under complete physiological conditions without 
unduly disturbing the animal.  Use of this method for measurement of pulsatile GnRH, 
LH and FSH secretion is possible only in equids due to the unique venous drainage of the 
pituitary and the arrangement of the equine cranial vasculature.  Investigators showed 
that radiographs could be used to help overcome misplacement of the cannula and that 
chewing, changes in head position or vascular reaction of the cannula itself had no effect 
on the concentrations of the hormones on ICS effluent [45]. 
There are a few studies that have reported the use of this technique during various 
periods of the ovulatory and anovulatory seasons.  Silvia et al. [46] determined pulsatile 
patterns of LH and FSH in the ICS and in peripheral jugular blood samples.  They found 
no correlation between the pulsatile patterns of gonadotropins in the pituitary blood (ICS) 
and those in jugular blood during the follicular phase.  Throughout the luteal phase, the 
frequencies of LH and FSH pulses in the ICS were 0.6 and 1.8 pulses in 8 h, respectively.  
During the follicular phase, frequencies increased to 7.4 and 6.8 pulses in 8 h, 
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respectively for each hormone.  Pulses generated during the follicular phase were not 
detected in jugular blood, although the pulses detected during the luteal phase were  
recorded in peripheral plasma because of their greater amplitude [46].  Similar results 
were reported by Irvine and Alexander [47].  During mid-diestrus, a total of four peaks of 
LH and FSH were detected in a combined sampling period of 75 h in pituitary venous 
blood.  These peaks were also detected in jugular blood and they were not associated with 
an immediate increase in progesterone concentrations in peripheral plasma.  On the other 
hand, during the follicular phase, peak frequency was greater with 28 peaks of each 
gonadotropin in a combined sampling time of 80 h.  Only 57% of pituitary venous LH 
and 50% of pituitary venous FSH peaks were detectable in jugular blood.  Gonadotropin-
releasing hormone was detected during each peak of gonadotropin secretion throughout 
the first sampling and 65% during the second sampling.  They suggested that GnRH 
pulses might not be concurrent with gonadotropin pulses during the ovulatory surge 
because of the influence of high plasma estradiol creating a de-synchronization of the 
firing of GnRH neurons.  In our laboratory, GnRH, LH and FSH were measured during 
four different seasons.  No difference in FSH mean concentrations nor amplitude of 
pulses were detected among all seasons; however, there was a slight but statistically 
significant decrease observed in frequency of pulses of FSH during fall transition 
compared to all other seasons.  Mean concentrations of LH and amplitude of LH pulses 
were greatly reduced during fall transition, anovulatory season and early ovulatory season 
compare to the ovulatory season.  However, contrary to the accepted dogma, neither the 
frequency of LH pulses, nor the frequency and amplitude of GnRH pulses changed 
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between seasons [13]. Furthermore, the mechanisms regulating the decrease in LH during 
anovulatory season remain to be elucidated.  
2.2 Neuropeptide regulation of seasonality 
2.2.1 Role of melatonin in seasonal breeding 
 Photoreceptors in the eyes respond to light excitation and provide signals to the 
pineal gland through retinohypothalamic and suprachiasmatic neurons that modify the 
synthesis and secretion of melatonin.  The nocturnal duration of melatonin secretion is 
greatest during fall and winter months when nights are the longest.  Evidence from one 
study with mares indicated that melatonin reduces GnRH content of the hypothalamus 
[48], suggesting that gonadotropes may lack adequate stimulation to synthesize and 
secrete LH during the winter anovulatory period.  Moreover, the action of melatonin is 
mediated by specific high-affinity, membrane-bound receptors that inhibits GnRH-
induced calcium release from the endoplasmic reticulum as well as calcium influx 
through voltage-channels in the gonadotrops.  Melatonin also inhibits GnRH-induced 
accumulation of cAMP in the gonadotrops , which may result in the decreased influx of 
calcium, because cAMP, acting through protein kinase A, stimulates calcium influx into 
the gonadotrophs [49].  Fitzgerald and Schmidt [2] found that, during the winter 
anovulatory season, concentrations of melatonin in plasma increased during the night 
time in both non-cycling and cycling mares, although, for some individuals, a rise in 
melatonin concentrations was absent.  Furthermore, Fitzgerald and McManus [50] found 
that the administration of melatonin to mares failed to significantly alter the onset of the 
anovulatory period.  The idea that melatonin reduces GnRH content in the hypothalamus 
is indirectly supported by Hart et al [51].  In their study, hypothalamic content of GnRH 
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varied within seasons and was lowest during mid-anestrus.  However, different results 
were obtained by Silvia et al. [52], who observed no difference in the hypothalamic 
content of GnRH during different seasons.  In a recent study in our laboratory, a marked 
reduction in secretion of LH occurring around the autumnal equinox and continuing 
throughout the winter anovulatory period did not appear to be accompanied by a similar 
reduction in pulsatile secretion of GnRH in the ICS [13].  This is somewhat paradoxical 
because, when GnRH is injected in a pulsatile manner into anovulatory mares during the 
spring at a rate as low as 2 g/h, an increase in secretion of LH is observed coincidentally 
with follicular development and ovulation [6].  In the late winter (second week of 
January), pulsatile infusion of GnRH at a rate of 20 g/h increased plasma concentrations 
of LH and caused ovulation within 12 d [10].  This suggests that GnRH is indeed limiting 
during the anovulatory period.  
 Seasonal reproduction in sheep is also influenced by day length and regulated by 
the pineal hormone, melatonin.  However, contrary to the mare, melatonin has a positive 
effect on reproduction in the ewe [53].  The use of melatonin microimplants placed in the 
premammillary hypothalamic area (PMH) stimulated secretion of LH, suggesting that 
this is a melatonin target area mediating seasonal reproduction in the ewe [54].  However, 
exogenous treatment with melatonin that advances the onset of the breeding season in the 
ewe did not appear to do so by direct stimulation of LH and FSH concentrations in the 
peripheral blood [54].  To date, although there is some understanding of how melatonin 
influences reproduction in seasonal breeders, there remains a need for more work to 
precisely understand the mechanism involved  in this process.   
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2.2.2 Gonadotropin-inhibiting hormone 
Gonadotropin releasing hormone has historically been considered to be unusual 
among hypothalamic neuropeptides in that it appeared to have no direct antagonist, 
although some neurochemicals and peripheral hormones (opiates, GABA, gonadal 
steroids, inhibin) can modulate gonadotropin release to a degree [55].  Recently, several 
new neuropeptides involved in the regulation of GnRH have been found that have 
consequent effects on LH and FSH secretion.  A novel neuropeptide involved in 
regulating reproduction is gonadotropin-inhibiting hormone (GnIH).  This neuropeptide 
was found initially in seasonally-breeding avian species and is part of the so-called RF-
amide-related peptide family [56].  Gonadotropin inhibiting hormone is a dodecapeptide 
with a C-terminal Leu-Pro-Leu-Arg-Phe-NH2 sequence that has been shown to have 
negative regulatory effects of LH.  Gonadotropin-inhibiting hormone-like 
immunoreactive neurons were localized throughout the encephalic and diencephalic 
regions in avian  species; however, precursor mRNA for GnIH was found to be expressed 
only in the paraventricular nucleus (PVN), which indicates that the PVN may be the only 
site for synthesis of GnIH [57].  Similar gene sequences have been discovered in the 
human, rat and bovine hypothalamus encoding amino acid sequences very similar to 
GnIH, characterized as RF-amide related peptide-1 (RFRP-1), RF-amide related peptide-
2 (RFRP-2) and RF-amide related peptide-3 (RFRP-3).  This indicates that these three 
peptides may have evolved from a common ancestor [57,58,59]. 
In rats, intracerebral ventricular (ICV) injection of RFRP-3 reduced plasma 
concentrations of LH but did not alter plasma levels of FSH [58].  Bentley et al. [55] 
showed that there is a close proximity of GnIH fibers to GnRH fibers and neurons 
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throughout the hypothalamus in birds and mammals.  It has also been demonstrated that 
GnIH decreases gonadotropin release from cultured anterior pituitary cells in songbirds 
and that GnIH-immunoreactive neurons inhabit larger areas in the hypothalamus at the 
end of the breeding season than at other times.  Moreover, Ubuka and collaborators [60] 
demonstrated that melatonin induces the expression of GnIH in quails.  Pinealectomy, 
combined with orbital enucleation, caused a concomitant decrease of GnIH precursor 
mRNA, content of mature GnIH peptide, and endogenous melatonin.  Administration of 
melatonin to these birds caused a dose- dependent increase in expression of GnIH 
precursor mRNA and production of mature peptide.  In addition, GnIH mRNA and GnIH 
peptide have been shown to be elevated during short days in quails, when melatonin 
secretion is known to be greatest [60]. 
  In our laboratory, we have also observed GnIH neurons and fibers in close 
proximity to GnRH neurons and fibers in the hypothalamus of the mare. (unpublished 
data).  These findings suggest that GnIH is present in the mare.  It is possible that GnIH, 
perhaps controlled by melatonin, could contribute to the abrupt decline in secretion of LH 
in the mare in the fall and winter, thus serving as an alternative mechanism to explain the 
development of the winter anovulatory state [13].  However, additional research will be 
required in order to confirm this hypothesis and to determine where and how GnIH could 
work to effect such a result. 
2.2.3 Kisspeptin  
 Kisspeptin is a neuropeptide produced in the hypothalamus that also belongs to 
the family of RF-amide proteins.  Kisspeptin has an Arg-Phe-NH2 C-terminal sequence 
characteristic of this family of peptides that bind to the G-protein coupled receptor, 
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GPR54 and appears to act as a stimulator of GnRH secretion [61].  Messager and 
coworkers [61] showed that GPR54 transcripts colocalize with GnRH in neurons.  They 
also demonstrated that the central administration of kisspeptin in sheep produces a 
dramatic release of GnRH into cerebrospinal fluid.  Another recent study showed that 
constant intravenous infusion of kisspeptin into ewes induces a sustained release of LH 
and FSH during the breeding season [62].  During the anestrous season, intravenous 
treatment with kisspeptin at a rate of 12.4 nmol/h, for either 30 or 48 h, caused ovulation 
in 80% of treated ewes compared with 20% of saline-treated controls [62].  Dungan and 
collaborators [63] found that in mice the deletion of the GPR54 gene produces 
hypogonadotropic hypogonadism, without any other obvious phenotypic abnormalities.  
A different group of investigators showed that, in the rat, kisspeptin expression is up-
regulated by estradiol at the level of the pituitary and that GPR54 is up-regulated by 
GnRH which exclusively targets gonadotrophs [64].  Administration of kisspeptide 
results in increase in FSH and LH secretion in the mare (ref attached), but its relationship 
to seasonality has not been investigated [65].  
2.3 Control of seasonal breeding in mares 
2.3.1 Artificial lighting 
The universal birth date (January 1) for foals imposed by many breed 
organizations has caused a misalignment of the operational and natural breeding season 
of the mare.  Supplemental lighting programs have been used for many years to induce 
earlier onset of spring transition in winter anovulatory mares.  Exposure to 15-16 h of 
daylight, beginning in early to mid-December, stimulates follicular development and 
advances the time of ovulation in anovulatory mares [5].  Mares exposed to 24 h of light 
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continuously had increased circulating concentrations of LH in daily samples compared 
to mares exposed to 12 h of light and 12 h of darkness.  Similarly, an increase in GnRH 
content of the hypothalamus in the 24-h light group was also observed [4].  Kooistra and 
Ginther [66] showed that 15.5 hours of light from the summer solstice through the 
following winter was an effective method for hastening the onset of the ovulatory season.    
 Scraba and Ginther [67] tested different lighting programs for their efficiency in 
hastening the onset of the ovulatory season.  Fifteen and one-half h of light and 8.5 h of 
dark were applied starting at three different time of the year; summer (July, August), late-
fall (November, December) and winter (January).  All treated mares entered the ovulatory 
season earlier than control mares under natural day-length.  However, the average date of 
the first ovulation after January 1 was one month earlier for the late-fall group than for 
either the summer or the winter group.  Moreover, beginning the lighting program during 
the winter was less efficient than beginning the program in late-fall.  A combination of 
artificial long-day photoperiod and 40 g of the GnRH agonist, buserelin at 12 h intervals 
for 28 days during late winter/early spring increased serum concentrations of LH  within 
6 wk, whereas the mares in ambient lighting required 12 wk to respond to GnRH [68].  
 To investigate the influence of day length on the seasonal reproductive cycle of 
the stallion, Clay and Squires [69] assigned 21 stallions to one of three treatments: 1) 
control (natural photoperiod), 2) S-L (8 h light and 16 h dark for 20 weeks and then 16 h 
light and 8 h dark from December 2, 1982 until March 5, 1984), 3) S-S 8 h light and 16 h 
dark from July 16, 1982 until March 1984.  The stimulatory effects of long photoperiod 
resulted in larger testes, decreased time to ejaculation and more sperm output for S-L 
stallions in February than November for both years of evaluation.  However, total scrotal 
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width and sperm output for S-L stallions eventually declined, presumably as a 
consequence of photorefractoriness.   
 Artificial lighting programs are a good option for advancing the onset of cyclicity 
in mares.  Unfortunately, they can often require a large investment in physical 
infrastructure.  
2.3.2 Treatment of mares with exogenous GnRH 
 Hormonal treatment methods that have been used to accelerate the onset of 
cyclicity in mares have included the administration of both native GnRH and GnRH 
agonists.  Hyland and collaborators [70] found that GnRH administered at a rate of 40-60 
g/h continuously for 28 days during the spring transitional period could induce fertile 
estrus.  In studies conducted in our laboratory, continuous administration of low-dose 
GnRH (2.5 to 5 g/h) was successful in stimulating a small increase in LH and hastening 
the onset of first ovulation in mares exhibiting persistent anovulation during the ovulatory 
season [11].  Becker and Johnson [6] treated seasonally anovulatory mares and cyclic 
mares with GnRH in both a pulsatile (20 g/h) and continuous manner (2-20 g/h).  They 
concluded that the mode of GnRH infusion (i.e., pulsatile vs continuous) does affect 
differentially the secretion of LH.  Anovulatory mares that were treated with pulsatile 
GnRH ovulated on average 2.8 d earlier than those treated with GnRH continuously, 
although all mares ovulated in the three groups.  Moreover, circulating concentrations of 
LH in cyclic mares treated with a constant infusion of GnRH were lower on the day of 
ovulation than in both control mares and those treated with GnRH in a pulsatile manner.  
McCue and collaborators [7] showed that seasonally anestrous mares treated with native 
GnRH (10 g/h) injected subcutaneously with a peristaltic pump in a pulsatile manner 
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resulted in a greater follicular development than that in mares treated with 10 g of a 
GnRH agonist (buserelin) injected s.c twice daily.  Concentrations of serum LH in mares 
induced to ovulate with native GnRH were greater (7.4 ng/mL) than those induced with 
the agonist (1.8 ng/mL).  Both treatments induced ovulation in 11/14 and 10/17 mares for 
the native GnRH and analog, respectively, and each ovulation was followed by a normal 
luteal phase. 
 Although a number of studies have shown that the onset of follicular development 
and ovulation in anovulatory mares can be advanced with GnRH treatment beginning 
soon after the winter solstice, there is only one reported study in which this has been 
attempted before the winter solstice.  Collins et al. [12] showed that continuous, low-dose 
infusion of GnRH (2.5 g/h-5.0 g/h), beginning in October and continuing through 
March, was unable to prevent the onset of seasonal anovulation in the fall or to advance 
the timing of ovulation in the spring.  Similar doses of GnRH were previously shown to 
be effective in about 80% of persistently anovulatory mares during the natural breeding 
season.  One explanation for the different responses noted between the two studies is that 
gonadotropes may be less sensitive to GnRH stimulation before compared to after the 
winter solstice.  Day length decreases slowly before the winter solstice and increases 
slowly thereafter.  A previous report indicated that photoperiod and estradiol interact to 
increase the synthesis and secretion of LH in anestrus mares [71].  However, untreated 
mares under natural lighting have very little releasable LH in the pituitary even as late as 
March 31 [12].  Therefore, endogenous stimulation of gonadotropes by GnRH under 
natural photoperiod should not substantially complicate the ability to compare 
responsiveness to GnRH in December vs February.  
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 The sustained release of GnRH agonist from implants has also been shown to 
hasten ovulation.  Treatment with deslorelin, a GnRH analog, is a consistent method of 
inducing ovulation in cyclic mares during the breeding season [72] and is currently 
marketed in a sustained-release implant form as Ovuplant (Ft. Dodge Animal Health, 
Overland Park, KS).  Squires and collaborators [72] conducted a series of dose-response 
studies to evaluate the efficacy of this synthetic agonist for hastening ovulation of mature 
preovulatory follicles in nonlactating cyclic mares.  They determined that 2.2 mg/mare of 
deslorelin induced ovulation in most of the mares having follicles of at least 37.7 mm 
diameter within 48 hours.  There was no effect of GnRH on pregnancy rates. On the other 
hand, Mumford et al. [73] reported that use of a GnRH agonist in implant form, 
administered at varying doses to induce ovulation in transitional mares, resulted in only 
15 of 100 mares ovulating within 30 days of treatment.  Similarly, Fitzgerald et al. [74] 
found that constant administration of the GnRH agonist, goserelin acetate, failed to 
induce ovulation effectively  in anovulatory mares.
Harrison et al [68] treated transitional mares for 28 days with a GnRH agonist 
(buserelin), administering 40 ug of buserelin per injection every 12 hours i.m..  He 
reported ovulation in 7/15 treated mares compare to 0/15 ovulations in the untreated 
control group. 
2.3.3 Desensitization of the anterior pituitary to GnRH 
 In mammals, continuous treatment with GnRH generally results in GnRH 
receptor down-regulation, producing a desensitization of anterior pituitary gonadotropes 
to GnRH.  In mares, this down-regulation seems relatively less robust.  Porter and Sharp 
[9] studied the ability of mares and sheep to respond to continuous treatment with GnRH 
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during diestrus.  Results indicated that GnRH administered continuously to ewes at a rate 
of  20 µg/h resulted in an initial increase followed by a decline to basal concentrations 
that are typical of GnRH receptor down-regulation.  However, treatment of mares 
continuously with GnRH up to 110g/h resulted in sustained secretion of LH.  In the 
same study, mares and ewes were treated with GnRH using both pulsatile and continuous 
modes of treatment.  Doses used for the mares were 25 g/h for hourly- pulsatile and 110 
g/h for continuous treatments, respectively.  Doses used for the ewes were 25 ng per 
hourly pulse and 2.5 g/h continuously for 5 days.  For both treatments, there was an 
increase in LH at day 5 in mares, while in ewes continuous treatment produced a marked 
suppression in secretion of LH. Concentrations of LH in ewes treated with pulsatile 
GnRH did not differ from contols [9].  In order to understand this phenomenon, an 
additional study was completed to investigate the structure and intracellular trafficking of 
the equine GnRH receptor [75].  Results indicated a slow rate of receptor-mediated 
endocytosis which apparently contributes to the observation that equine pituitary cells 
maintain the ability to bind radiolabeled GnRH in the presence of excess unlabeled 
GnRH.  Additionally, there are a few amino acid substitutions that appear distinct to the 
equine GnRH receptor gene sequence.  These may contribute to the relative capability of 
the equine receptor to resist desensitization [75].  However, the basis of the ability of 
continuous GnRH administration to stimulate secretion of LH in the mare remains to be 
fully elucidated.  One early observation made by Alexander and Irvine [3] was that when 
the exogenous GnRH signal is continuous in the mare, LH secretion seems to remain 
pulsatile in pituitary venous blood.  However, an in-depth study to test this hypothesis 
using the ICS cannulation technique remains to be conducted.  If confirmed, then the 
 23 
continued pulsatility of LH release would suggest that small endogenous GnRH pulses 
are  being superimposed on the continuous background of exogenous GnRH.  This argues 
that during continuous infusion the GnRH signal to the pituitary remains, in part, 
intermittent [3]. 
 The continuous administration of potent GnRH agonists in the mare results in 
findings different from those summarized above for native GnRH.  Use of the GnRH 
analogue, deslorelin acetate, in cyclic mares to induce ovulation prolonged the 
interovulatory interval by 6.2 days when luteolysis was induced with PGF2.  These 
mares had suppressed LH and FSH concentrations for up to 11 days after ovulation [76].  
When a group of geldings treated with progesterone and estradiol to mimic the estrous 
cycle of the mare were treated with deslorelin acetate (Ovuplant), the implant suppressed 
both LH and FSH concentrations for at least 14 days.  Similar observations were made 
for a group of stallions [77].  Importantly, prolonged exposure of mares to residual 
hormone remaining in the Ovuplant implant resulted in ovarian quiescence for an 
extended period up to 17.5 ± 7.2 days in some mares.  Farquhar and collaborators [78] 
found that removal of the deslorelin implant in mares after 2 days of treatment prevented 
the subsequent decrease in gonadotropin concentrations and follicular growth.  
 In male sheep [79], dogs [80,81], rhesus monkeys [82,83], rats [84,85] and 
humans [86], continuous exposure to GnRH agonists suppresses the activity of the 
pituitary-gonadal axis.  In a study with postpartum acyclic cows, while continuous long-
term GnRH and GnRH-agonist treatment induced an earlier first ovulation, it resulted in 
failure of a second ovulation following luteal regression [87].  D’Occhio et al. [88] used 
200 or 400 ng of native GnRH/kg body weight per h and 5.5 or 11 ng of  the GnRH 
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buserelin/kg body weight per h that were delivered continuously using osmotic mini-
pumps designed to remain active for 28 days.  All treatments increased mean basal 
circulating LH concentrations, but 3 cows, one each from the 400 ng GnRH, 5.5 ng 
buserelin and 11 ng buserelin , showed evidence of low levels of LH and FSH  by failing 
to show a second ovulation.  Authors explained that this could have been due to 
insufficient FSH stimulation for early follicular development, or the absence of an 
endogenously driven LH surge [88].  A further study was conducted to examine if 
buserelin could be used as a controlled, reversible suppressor of the estrous cycle in beef 
heifers and cows [89].  Two groups of cyclic heifers were treated with either two or four 
buserelin implants (3 mg) and degree of cessation of estrous cycles was monitored.  Both 
groups stopped cyclicity as indicated by basal progesterone concentrations (0.2 ng/ml).  
When cows were implanted with four implants on day 7 of their ensuing cycle for either 
28 or 56 days, those cows ceased exhibiting ovarian cycles as well; however, when 
implants were removed, estrous cycles resumed in all animals [89].  A different group of 
investigators treated prepubertal heifers with GnRH subcutaneously at a rate of 5 µg/h for 
12 days.  All heifers showed an immediate pituitary response to GnRH stimulation, with 
serum values of LH reaching preovulatory surge levels within 2-4 h after pump insertion 
that remained higher than pretreatment values until treatment removal.  They concluded 
that continuous infusion of the GnRH at a rate of 5 g/h for 12 days seems to be effective 
in stimulating a long-lasting pituitary response in prepubertal heifers [90].  Similarly, 
when prepubertal bulls were treated with a GnRH agonist, azagly-nafarelin, for an 
extended period, basal concentrations of LH were greater for the treated group than they 
were for controls.  However, frequency of LH pulses in the agonist-treated group was 
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reduced to less than one pulse in 24 h [91].  D’Occhio and Aspden [92] treated young 
bulls with deslorelin using dosages ranging from approximately 0.15 to 0.29 µg 
deslorelin/kg live body weight per day.  All dosages increased plasma LH concentrations 
that declined after 24 h; however LH pulses were abolished by the treatments.  The data 
suggested that the anterior pituitary in bulls became desensitized after receiving LHRH 
agonist treatments.  Collectively, the foregoing suggests that basal concentrations of LH 
can be chronically elevated to a minor degree in some species using continuous GnRH 
and GnRH agonist treatments.  However, these effects appear to be working through 
signaling mechanisms within the gonadotrope that somehow elevate LH at the baseline 
while abolishing typical pulsatile release patterns associated with normal anterior 
pituitary and gonadal function.  
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CHAPTER III 
EFFECTS OF CONTINOUS TREATMENT WITH EXOGENOUS GnRH ON 
TEMPORAL CONCENTRATION PATTERNS OF LH IN THE 
INTERCAVERNOUS SINUS OF THE CYCLIC AND ANOVULATORY MARE 
 
3.1 Introduction 
 The continuous administration of exogenous GnRH and its synthetic agonists to 
most mammalian species results in a general down-regulation of the GnRH receptor, thus 
desensitizing the anterior pituitary to their stimulatory effects and markedly reducing 
secretion of LH.  However, in the horse, continuous infusion of native GnRH at doses 
greater than 100 µg/h remains stimulatory [9], although this is not generally true for its 
more potent synthetic agonists [78].  In addition, Alexander and Irvine [3] proposed that 
secretion of LH in the mare remains pulsatile even when GnRH stimulation is constant.  
This hypothesis has not been critically tested, and little is known about the hypothalamic-
pituitary interrelationships that would subserve such a unique phenomenon.  
 Mares also exhibit profound reproductive seasonality, and varying strategies have 
been used to accelerate gonadotrope recrudescence for secretion of breeding season 
levels of LH [6,7,10].  This, in turn, would promote earlier breeding and subsequent 
foaling during the calendar year.  Previous work in our laboratory has shown that low 
doses of continuously-administered, native GnRH (2.5-5 µg/h sc) are unable to prevent 
the development of or to reduce the length of winter anovulation [12].  However, the 
administration of similar doses in April successfully induced follicular development and 
ovulation in approximately 80 % of persistently anovulatory mares, suggesting that the 
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anterior pituitary may be less responsive before or near the winter solstice than after [11]. 
Therefore, the question remains as to whether the seasonal anovulatory state is controlled 
solely by a limitation of endogenous GnRH secretion or changes associated with pituitary 
responsiveness.  Additional studies in our laboratory, utilizing the intercavernous sinus 
(ICS) sampling technique [13] that allows the measurement of pulsatile secretion of both 
GnRH and gonadotropins, found that nor frequency nor amplitude of GnRH pulses  
changed over season, resulting in the conclusion that GnRH release may not be limiting 
during the anovulatory season [13].  These findings are contrary to accepted dogma 
which suggests that the lack of an adequate GnRH signal to the anterior pituitary is the 
primary cause of seasonal anovulation.  Therefore, additional experiments are required in 
order to resolve this conflict and to more fully understand the unique interrelationships 
that appear to exist between the hypothalamus and anterior pituitary in horses.  The 
objectives of the current studies were 1) to investigate the responsiveness of 
gonadotropes to continuous GnRH infusion in cyclic mares during the breeding season, 
and 2) to examine whether discernable changes in anterior pituitary responsiveness to 
continuous GnRH exists in anovulatory mares near and after the winter solstice.  
3.2 Materials and methods 
 The Institutional Agricultural Animal Care and Use Committee of the Texas 
A&M University approved in advance all procedures used in these studies. 
3.2.1 Experiment 1 
3.2.1.1 Animals    
 Ten Quarter horse mares, provided by a local breeder were maintained on pasture 
(Coastal Bermuda grass) at the Texas AgriLife Research Station-Beeville and 
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supplemented with a mixed grain concentrate (14% crude protein; Falls City Milling, 
Falls City, TX) to maintain a minimum body condition of 5 (1 to 9 scale).  Eight of the 
ten mares had suckling foals at side until weaning at 4 mo of age.  Estrous cycles were 
monitored by daily teasing with two stallions and transrectal ultrasonography was 
employed three times weekly to estimate day of ovulation (define as Day 0).  Teasing 
scores used were as follows: 1-breaks down, urinates; 2-winking, intense interest in 
stallion; 3-some interest in stallion; 4-passive; 5-rejects stallion.  
3.2.1.2 Experimental procedures   
 Mares were assigned randomly to one of two groups: 1) GnRH (continuous 
intravenous infusion of 100 µg/h; n=5) or 2) Control (continuous intravenous infusion of 
saline; n=5).  The GnRH or saline treatments were delivered via an Alzet osmotic pump 
(Model 2ML1; Alza Scientific Products, Palo Alto, CA) that was placed surgically under 
the skin of each mare and connected to a catheter placed in the external jugular vein.  
Pumps were inserted between Days 3 and 6 after ovulation (Day 0 of treatment).  
Pumping rate for the lot of pumps used in this experiment was 9.15 l/h, allowing for 
continuous function up to 7 d.  Therefore, concentration of GnRH in the loaded pumps 
was 10.9 g/l, resulting in delivery of GnRH at a rate of 100 g/h.  Daily blood samples 
from the contralateral jugular vein were collected by venipuncture beginning immediately 
before pump insertion and continued until pump removal on Day 6 of treatment.  On Day 
3 after initiation of treatments, (Days 6 to 9 after ovulation), the ICS was catheterized via 
the facial vein for intensive blood sampling [45].  Catheterization was performed under 
light sedation and using a local anesthetic as described in detail below.  Catheterization of 
ICS was used for collection of intensive blood samples on Days 4 and 6 of the 
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experiment.  On each day of sampling, mares were heparinized (30,000 IU sodium 
heparin, iv.), tied loosely and provided with hay and water during the procedure.  On the 
day following ICS catheterization (Day 4 after onset of treatment; Day 7 to 10 after 
ovulation), 5-mL ICS blood samples were collected over 15 sec every 5 min during 8 h to 
determine concentrations of LH during the luteal phase by radioimmunoassay (RIA).  
Samples were placed into tubes containing 50 µl of a 5% EDTA-heparin solution (10,000 
IU/mL) to prevent coagulation and 100 µl of a 50 mM solution of Bacitracin (Sigma 
Chemical Co., St Louis, MO USA). The latter was added to minimize metabolism of 
GnRH.  However, for the purpose of this report, GnRH was not measured in these 
samples.  Samples were placed immediately on ice and centrifuged (5125 x g) for 
collection of plasma within one h of collection.  Plasma was stored at -20 oC until used 
for hormone analysis.  Immediately following the first intensive ICS blood sampling, 
mares were injected with 2 mL of PGF2 im (10 mg Lutalyse, Pfizer, New York, NY) to 
regress the CL.  A second intensive ICS blood sampling was performed 36 hours after 
PGF2 injection (Day 6 of experiment, early follicular phase; Fig 1).  Upon completion of 
the last ICS sampling period, catheters and pumps were removed and mares were 
returned to the pasture.  The skin overlying the site of cannulation and pump was 
inspected daily and treated with a topical antiseptic/antibiotic as required until healed.  A 
time-line of the experimental procedures is shown in Fig. 1.  
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Figure 1. Time line of procedures for experiment 1 relative to day of ovulation and day of 
experiment in individual mares. 
 
 
 
3.2.1.3 Intercavernous sinus catheterization procedure 
 Catheterization of the intercavernous sinus (ICS) was performed following 
procedures described previously [3,13,46].  The mare was placed in a stock and sedated 
with detomidine (Dormosedan, 20-40 µg/kg BW Pfizer, Ney York, NY).  The facial vein 
lies parallel to and along the anterior border of the mandible.  An area centered over the 
line of the mandible and extending in all directions for approximately 2 to 2.5 cm was 
clipped, scrubbed and disinfected for aseptic surgery.  The facial vein was detected by 
palpation and an area (approximately 1 cm x 1 cm) overlying and surrounding the vein, 
but below the facial crest, was infiltrated subcutaneously with 2% Lidocaine HCl (Vedco, 
Inc, St Joseph, MO).  A 1-cm skin incision was made over the vein, and the vein was 
exteriorized using blunt dissection and held in the exteriorized position by placing a 
sterile probe between the vein and the underlying tissue.  A small cut was made in the 
vein while occluding blood flow, and a Tygon catheter (0.04 i.d. x 0.07 o.d.; Norton 
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Performance Plastics Co, Akron, OH) was inserted into the vein.  A flexible stylette was 
maintained in the catheter and the catheter was gently threaded up the vein.  The 
objective was to thread the catheter cranially to the base of the cranial cavity.  A lateral 
radiograph was taken to visualize the position of the catheter and verify that it was 
located in the ICS (Fig 2).  If the catheter was off target, it was removed and rethreaded.  
Once in place, the stylette was removed and a heparin (10,000 IU/mL) lock was placed in 
the tubing to prevent clotting.  The tubing was sutured with synthetic sutures (Supramid; 
Burns Veterinary Supply, Inc, Westbury, NY) above and below its exit to the skin and the 
skin was partially closed and dressed with a wound dressing.  During ICS blood 
sampling, the mares were heparinized with 30,000 IU heparin every 3 h.  Catheters, when 
not being used for intensive sampling, were flushed once or twice daily with 3 to 5 mL 
heparinized saline (10,000 IU). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Lateral radiograph post-catheterization. Arrows help identify the catheter 
with the guide wire still in place as it travels toward the cranium into the ICS and the 
tip resting just below the orbit of the eye. 
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3.2.1.4 Alzet osmotic mini-pump insertion 
 The mare was placed in a stock and sedated with detomidine (Dormosedan, 20-40 
µg/kg BW) if required.  An area on the jugular grove measuring approximately 3 x 3 cm 
was clipped, scrubbed with an iodophore, and disinfected with dilute chlorhexidine 
solution (Vedco, Inc, St Joseph, MO) and povidone iodine solution (Prepodyne, 
WestAgro, Kansas, MO).   Three to five ml of 2% Lidocaine HCl was injected sc and a 
1.5 to 2-cm incision was made through the skin with a sterile scalpel.  A sterile, blunt 
instrument was used to expand the subcutaneous space making a pocket to accommodate 
the Alzet pump containing GnRH diluted in saline or saline only.  Another small incision 
was made for inserting a 12-gauge needle in the jugular vein.  A polyethylene catheter 
(Becton Dickinson and Company, Sparks, MD) was inserted in the vein trough the needle 
and connected subcutaneously to the pump.  The incision was closed with #2 synthetic 
sutures (Supramid) or other suitable non-absorbable suture that is left in place for 7 days.  
The wound was dressed with a wound dressing.  On the last day of the experiment (Day 
eleven), the incision was re-opened, the pump was removed, and the incision was closed 
with a non-absorbable suture.  Sutures were removed 7 d later. 
3.2.2 Experiment 2 
 3.2.2.1 Animals  
 Fifteen mares were maintained on pasture (Coastal Bermuda grass) and 
supplemented with a grain mixture concentrate as for Experiment 1 to maintain mares in 
good body condition.  Before the study, all mares were examined weekly using 
transrectal ultrasonography to determine onset of the seasonal anovulatory (non-cycling) 
period.  In addition, blood samples from the jugular vein were collected twice weekly for 
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determination of serum concentrations of progesterone as an adjunct to ultrasonography 
for assessing luteal function.. 
3.2.2.2 Experimental procedures 
  Mares were classified as anovulatory based on serum concentrations of 
progesterone (P4) less than 1 ng/ml for at least 3 wk, visual confirmation of absence of 
corpora lutea by transrectal ultrasonography and no follicles greater than 30 mm.  Three 
mares were considered to have residual follicular activity because they had follicles 
larger than 30 mm, however they had not ovulated in a 21 days.  At the onset of the 
experiment (approximately Dec. 5), mares were assigned randomly to a control or one 
of two GnRH treatment groups: GnRH-20, 20 µg/h; and GnRH-100; 100 µg/h.  A sham 
pump constructed of Silastic tubing (Dow Corning Corporation, Midland, MI) and 
filled with medical grade Silastic adhesive (Dow Corning Corporation, Midland, MI) 
was surgically implanted under the skin for 14 days in control animals.  Alzet osmotic 
minipumps (model 2ML2; Alza Scientific Products, Palo Alto, CA) were surgically 
implanted under the skin to deliver GnRH treatments for 14 days.  A blood sample was 
collected daily for 14 days from the jugular vein to determine serum concentrations of 
LH.  Treatments were applied between December 5 and 20.  Transrectal 
ultrasonography was performed every 2 to 3 days to monitor ovarian follicular 
dynamics.  At the end of the 14-day experimental period, all pumps and sham pumps 
were removed.  The experiment was repeated beginning on February 15 with the same 
mares assigned to the same groups.  
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3.2.2.3 Alzet osmotic mini-pump insertion 
 The procedure for pump insertion was identical to that described for Experiment 1 
except that hormone delivery was subcutaneous and pumps were loaded with GnRH in 
saline at a concentration of 4.27 g/l and 21.36 g/l of GnRH for delivery of the 20 
g/h and the 100 g/h doses, respectively.  Pumping rate of the lot of pumps used in this 
experiment was 4.6 g/h. 
3.2.3 Hormone analyses 
 Concentrations of LH were analyzed by double antibody RIA for all intensive 
samples collected, as validated previously in this laboratory [11].  A highly-purified 
equine LH (eLH AFP-5130A) preparation was used for both iodinated tracer and 
standard.  An anti-eLH antiserum (AFP-240580) is used at a dilution of 1:120,000 which 
yielded 35.9% binding on average at B/O.  The sensitivity, intra- and interassay 
coefficients of variation (CV) for experiment 1 were 0.1 ng/ml, 5%, and 4.1% 
respectively.  For experiment 2, the sensitivity, intra- and interassay CV were 0.1 ng/ml 
13.8% and 1.4% respectively.  Concentrations of progesterone in serum were measured 
using a commercial single antibody kit (Diagnostic Products Corporation, Los Angeles, 
CA) for all jugular samples collected.  All samples within each experiment were analyzed 
for progesterone in a single assay.  Sensitivity for progesterone assays was 0.1 ng/ml, and 
intra-CV was less than 2% for Experiments 1 and 2. 
3.2.4 Pulse analysis  
 As noted earlier by Irvine and Alexander [45], patterns of episodic secretion of 
LH determined in the ICS often do not conform to those commonly described in the 
peripheral blood.  Furthermore, existing pulse detection algorithms commonly used for 
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detection of pulses of hormones did not provide a consistent assessment of apparent high 
frequency episodes of LH observed in Experiment 1.  Therefore, LH data for intensive 
sampling in Experiment 1 were transformed using 3-point rolling average to reduce 
background noise and assist in the identification of episodes of LH release.  This process 
improved the detection of secretory episodes and confirmed episodes identified 
subjectively.  A secretory episode was defined as an elevation of LH from the baseline of 
at least 0.1 ng/ml that was sustained during two consecutive samples.  Therefore, this 
approach was utilized for final pulse detection analyses for LH.  Duration of secretory 
episodes was determined as the time elapsed from the first elevation from the baseline to 
the following nadir 
3.2.5 Statistical analysis 
Data were analyzed using the Proc Mix procedure of SAS (SAS Inst., Inc., Cary, 
NC).  For experiment 1, the statistical model tested the effect of treatment on frequency 
and duration of episodes, and mean concentrations of LH, using “phase” as the repeated 
variable and “mare(treatment)” as the subject.  To test the effects of treatment on daily 
concentrations of LH and P4, “mare(treatment)” was used as the subject, “treatment”  
used as source of variation and “day’ and separately “phase” as the repeated variables. 
 For experiment 2, the statistical model for LH concentrations and changes in 
follicular size included main effects of treatment with season used as the repeated 
variable and mare as the subject.  Because there was a significant treatment by season 
interaction, day was used as the repeated variable to test the effects of “treatment” within 
each season for LH concentrations analysis.  There was no season interaction for changes 
in follicular size therefore data from both seasons were pooled together to proceed with 
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the analysis.  The Catmod procedure was used to analyze frequency of ovulation and 
frequency of estrus. 
3.3 Results 
3.3.1 Experiment 1 
Figure 3 represents a comparison of hormone data plotted for Mare 8 using values 
from 5-min samples and those generated using a 3-point rolling average.  Figure 4 
represents least-squares mean concentrations of LH during luteal (Day 4 post onset of 
treatment) and follicular (Day 6, following prostaglandin administration) phases, 
respectively, for control and GnRH-treated groups.  Concentrations of LH were markedly 
greater for the GnRH-treated mares compared to controls; and within the GnRH treated 
mares, concentrations of LH were greater during the luteal phase than during the 
follicular phase (P < 0.0001)  
 
 
 
Figure 3.  Five-min (left panel) and transformed three-point rolling average (right panel) 
patterns of LH in one representative control mare (Mare 8) during the follicular phase. 
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Figure 4.  Least-squares mean concentrations of LH (ng/ml ± SEM) during luteal and 
follicular phases determined in ICS blood samples collected at five-min intervals in five 
control and five GnRH-treated mares. *Means differed (P < 0.01). 
 
 
 
 Table 1 summarizes the number and duration of LH secretory episodes during 
both luteal and follicular phases in control and GnRH-treated mares.  During the luteal 
phase of control mares, the identified long-lasting episodes of LH release were followed 
by one to three secondary episodes.  Treatment with GnRH disrupted the infrequent, 
large secretory episodes of LH release and markedly increased (P < 0.01) the mean 
baseline and frequency of episodes during the luteal phase (Fig. 5).  Duration of episodes 
during the luteal phase lasted longer for the control group (P< 0.001) than they did for the 
GnRH treated group.  During the follicular phase, a high-frequency, episodic pattern of 
LH secretion characteristic of this phase was observed in control mares.  Treatment with 
GnRH increased (P < 0.001) the number of secretory episodes during the follicular phase 
(Fig. 5).  Duration of episodes of LH release lasted longer for the control group than it 
did for the GnRH treated animals (P< 0.001). 
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Table 1. Least-squares mean (± SEM) number and duration of LH secretory episodes 
during luteal and follicular phases.  
 
Treatment  Number of episodes (per h)  Duration of episodes (min) 
  Luteal 
phase 
 Follicular 
phase 
 Luteal 
phase 
 Follicular phase 
Control  0.175 ± 
0.2a 
 0.9 ± 0.2a  91.2 ± 6.1a  43.5 ± 2.2a 
GnRH  1.1 ± 0.5b  1.3 ± 0.4b  37.8 ± 2.0b  34.7 ± 2.2b 
*Means differ between treatments (P < 0.001). 
 
 
 Mean daily peripheral concentrations of LH are summarized on figure 6.  Mean 
LH did not differ on day 0, but 24 h after GnRH administration concentrations of LH 
increased 2.8 fold (P<0.04) and remained elevated throughout the experiment compared 
to controls.  Overall mean peripheral concentration of LH during the experimental period 
where greater for the GnRH treated mares compared to controls (P < 0.001) (Fig. 6).  
There was no treatment by phase interaction; therefore data were pooled by treatment.  
GnRH treatment also increased (P<0.03) mean serum progesterone concentrations 1.5 
fold during the luteal phase (experimental Days 0 to 4, Fig. 7).  Prostaglandin 
administration on Day 4 of the experiment regressed the CL in all mares, although mean 
progesterone concentrations were higher for the GnRH treated mares (0.7 ng/ml) than 
control mares (0.2 ng/ml) on the day of the second intensive sampling (follicular phase).     
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Figure 5.  Patterns of LH secretion (three-point rolling averages) in three representative 
control and three GnRH-treated mares during follicular (top panel) and luteal phases 
(bottom panel) respectively.  Pulses are denoted by an asterisk. 
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Figure 6.  Mean daily concentrations of LH (ng/ml ± SEM) throughout the experimental 
period (top panel) and overall mean concentrations of LH (ng/ml ± SEM) (bottom panel).  
Means did not differed on Day 0 but they did from Day 1 through Day 6 (P < 0.04) (top 
panel) and means differed between groups (P < 0.001) (bottom panel). 
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Figure 7. Mean serum concentrations of progesterone (± SEM) during the luteal phase. 
*Means differed between groups. (P< 0.03). 
 
 
3.3.2 Experiment 2 
The three mares with residual follicular activity were each assigned randomly one 
to each group, Control, GnRH-20 and GnRH-100.  All mares were anovulatory when the 
experiment was repeated in February.  
3.3.2.1 Hormonal responses 
  Near the winter solstice,  mean concentrations of LH increased beginning one day 
after onset of GnRH treatments in both GnRH-20 and GnRH-100 treatment groups, 
continued to increase through Days 11 to 14 (Fig. 8), and were markedly greater overall 
than controls (Fig. 9).  Mean concentrations of LH increased 10-fold in the GnRH-100 
group compared to controls, but only 2.4-fold in the GnRH-20 group (P < 0.001). 
When the experiment was repeated nearly 2 mo after the winter solstice, an 
increase in mean concentrations of LH was noted only in response to GnRH-100 
beginning one day after treatment onset.  Mean concentrations of LH increased 4.6-fold 
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in the GnRH-100 group but no changes were measured for the GnRH-20 compared to 
controls (Fig. 10).  The GnRH-20 treatment did not produce changes in LH 
concentrations throughout the second season compared to controls (Fig. 10).  Overall, 
mean concentrations of LH were greater (P < 0.001) in GnRH-100 than in controls and 
GnRH-20 groups (Fig. 11). 
3.3.2.2 Ovarian morphology  
 Season did not have an effect on follicle size changes between the two seasons.  
Therefore, follicle data were pooled across seasons.  Mean follicle size did not differ 
among groups at the beginning of each experiment (Day 0; Fig. 12), But mean largest 
follicle for both GnRH-20 and GnR-100 groups was larger (26.6 and 31.2 mm 
respectively) than the mean largest follicle for controls (19.1 mm) during the 
experimental period (Fig. 13).  However, when changes in follicle size, determined as the 
difference between mean size of largest follicle and mean size of follicle on day 0 of the 
experiment, only in the GnRH-100 group had changes in follicular size (P < 0.001) (Fig. 
14).    
3.3.2.3 Frequency of ovulation 
 Frequency of ovulation was not affected by season and a higher proportion of 
mares in the GnRH-100 group than in the other groups ovulated during both seasons 
compared to the other groups (P < 0.007).  Four of 5 mares treated with GnRH-100 
ovulated during the first season (winter solstice) and 2 of 5 mares in this group ovulated 
during the second season (two months post-winter solstice).  One mare in the 20-µg/h 
group ovulated during the first season (winter solstice); this was the mare observed with 
residual follicular activity in this group.  No ovulations occurred during the second 
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season for the GnRH-20 group and no ovulations occurred in the control group during 
either of the seasons (Table 2).   
 
 
 
Figure 8.  Daily mean serum concentrations of LH (ng/ml ± SEM) in control mares and 
mares in the GnRH-20 and GnRH-100 groups near the winter solstice (December 5 
through 20). 
 
 
Figure 9.  Mean serum concentrations of LH (ng/ml ± SEM) in control mares and mares 
in the GnRH-20 and GnRH-100 groups at the winter solstice.  Means with different 
superscripts (a,b,c) differed (P < 0.001 
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Figure 10.  Daily mean serum concentrations of LH (ng/ml ± SEM) in control mares and 
mares in the GnRH-20 and GnRH-100 groups after the winter solstice (February 15 
through 29). 
 
 
Figure 11.  Mean serum concentrations of LH (ng/ml ± SEM) in control mares and mares 
in the GnRH-20 and GnRH-100 groups after the winter solstice.  Means with different 
subscript (a, b) differed (P < 0.001). 
 
 
 
 45 
 
Figure 12. Mean follicle size on day 0 of experiment 2 (± SEM). Mean follicle size did 
not differ between groups on day 0 of the experiment. 
 
 
 
 
 
 
Figure 13.  Mean size of largest follicle of experiment 2 (± SEM). Means with different 
suscripst (a, b) differed. (P < 0.02 
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Figure 14. Mean changes in follicle size from day 0 of the experiment to largest follicle 
obtained during the experimental period. (± SEM).  Means with different superscripts (a, 
b) differed.  (P< 0.001). 
 
 
Table 2.  Frequency of ovulation near and after the winter solstice. 
 
Treatment  Season 
  Winter solstice  Post-winter solstice 
Control  0/5  0/5 
GnRH-20  1/5  0/5 
GnRH-100  4/5*  2/5* 
*Frequency of ovulation differed. (P < 0.007). 
 
 
3.3.2.4 Estrous behavior 
 Season did not have an effect on the frequency of occurrence of estrus. Only the 
GnRH-100 dose increased the frequency of estrus behavior during the experiment (P< 
0.003). However, during the post-winter solstice period, one mare out of the GnRH-20 
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and one mare out of the GnRH-100 group showed estrous behavior but did not ovulate 
(Table 3). 
 
 
Table 3. Frequency of estrus behavior near and after the winter solstice. 
 
Treatment  Season 
  Winter solstice  Post-winter solstice 
Control  0/5  0/5 
GnRH-20  1/5  1/5 
GnRH-100   4/5*   3/5* 
*Frequency of estrus behavior differed. (P < 0.003). 
 
 
3.4 Discussion 
 Results of studies reported herein indicate that continuous administration of 
GnRH stimulates secretion of LH and maintains its episodic release in mares.  
Furthermore, continuous GnRH stimulation in anovulatory mares appears to be less 
effective two months after the winter solstice than during the period near the winter 
solstice.  However, larger doses of GnRH (100 g/h) stimulated LH secretion, follicular 
development and ovulation at both times of the year.   
 In the current experiments, we observed a pulsatile pattern of LH release during 
both the luteal and follicular phases of the estrous cycle utilizing the ICS cannulation 
technique.  An earlier study reported that the majority of pulses of LH observed in 
pituitary venous effluent of the ICS are not observed in the peripheral circulation [46].  
This demonstrates the benefits of accessing the ICS blood for determinations of episodes 
of LH release.  During the luteal phase, when P4 is elevated, pulse frequency is depressed 
relative to the follicular phase due to negative feedback at the hypothalamic level [46].  
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Moreover, during the follicular phase, estradiol produced by the growing follicles 
stimulates LH synthesis and release [28].  
 In our experiment, observations of high-frequency, short-duration secretory 
episodes during the follicular phase, and low-frequency long-duration secretory episodes 
during the luteal phase of control mares, are in agreement with those reported previously 
[46,93].  Moreover, similar, to our results, Silvia et al. [46] described two distinct types 
of pulses during the luteal phase: 1) low amplitude-short duration and 2) high amplitude-
long duration.  In our study, we found short duration secretory episodes that were seen on 
the descending side of the long duration episodes in the control mares.  Similarly, Irvine 
and Alexander [93] described the pattern of LH during the luteal phase as concurrent, 
large amplitude, prolonged episodes that appeared to be the summation of a train of 
pulses.  These observations might explain the long duration of the LH secretory episodes 
during the luteal phase observed in the current study.  
 Alternatively, the long-duration episodes observed during the luteal phase of  
control mares might be attributed to variation in the secretory forms of LH during the 
estrous cycle that have been described in different species: horses [94,95,96], pigs [97], 
sheep [98, 99,100], cattle [101,102], goats [103] and birds [104].  In cattle, this 
polymorphism occurs due to variations in the structure of the oligosaccharides within the 
LH molecule which affect its physicochemical characteristics and the biological and 
immunological activities of the hormone [105].  Such variations might change the half-
life of the LH molecule, creating a long-lasting secretory episode. 
 Continuous infusion of GnRH (100 µg/h) during the breeding seasons not only 
stimulated an increase in concentrations of LH but also increased the number of secretory 
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episodes during both phases of the estrous cycle.  In rodents, humans, and sheep, 
exogenous administration of GnRH must be pulsatile, matching the typical pattern of 
endogenous GnRH release, in order to provide normal physiological stimulation of 
anterior pituitary gonadotropes [106,107,108].  Therefore, continuous administration of 
GnRH causes a reduction in LH release in these species, due to GnRH receptor 
desensitization or down-regulation [109,110].  When goats, sheep, cattle and monkeys 
are stimulated with exogenous pulses of GnRH, corresponding pulses of LH secretion are 
observed [9,111,112,113].  When pituitary cells from rats are cultured in vitro, they 
display refractoriness to constant perfusion of GnRH [114,115,116], but continue to 
respond indefinitely to pulses of GnRH [116].  This differential response occurs as a 
consequence of the rapid loss from cell membrane of GnRH receptors during continuous 
treatment [116].  This seems not to be the case in horses.  Several studies have provided 
evidence suggesting a resistance to GnRH receptor down-regulation in this species 
[9,117,118].  The equine GnRH receptor differs by 5 amino acids (Ser17, Ala26, His61, 
Asn69, and Phe226) from GnRH receptors in other species in which the sequence is known. 
These amino acids reside within the N-terminus, the first intracellular loop and the fifth 
transmembrane domain.  Additionally, similar to other mammalian GnRH receptors, but 
unlike many G-protein-associated membrane receptors, the equine GnRH receptor has no 
intracellular carboxy-terminal tail [74].  Cell surface binding does not decline in response 
to continuous GnRH exposure in the horse.  Instead, cell surface binding increases over a 
2-h period, indicating that the equine pituitary cell has the ability to provide additional 
GnRH receptors to the cell surface in the face of continuous ligand stimulation.  This is 
coupled with an apparent slow rate of endocytosis of occupied receptors [74].  These 
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differences might account for the ability of the equine GnRH receptor to resist 
desensitization when exposed to continuous GnRH.  
  Importantly, the release of LH in mares treated continuously with GnRH 
remained episodic, and this episodic pattern of LH release seems critical for gonadal 
function in other species.  Ovine ovaries infused constantly with LH produce only a 
transitory rise in P4 secretion, [119].  In male rats, prolonged exposure to constant LH or 
hCG impaired steroid secretion from testicular tissue [120,121].  Therefore, biological 
activity of LH at the gonadal level seems to require intermittent stimuli, which appear to 
be maintained even during continuous GnRH exposure in the mare. 
 The increase in frequency of secretory episodes of LH during the luteal phase in 
GnRH-treated mares compare to control could be attributed to an interaction of increased 
basal concentrations of GnRH induced by exogenous GnRH treatment with endogenous 
low amplitude but high frequency GnRH pulses.  With the elevation in baseline, low 
amplitude pulses of GnRH that would not generate a detectable episode of LH release 
could then reach the threshold necessary for stimulation of LH release.  This theory is 
supported by work with growth-restricted lambs, in which there is a central inhibition of 
GnRH activity [122].  Undernourished, hypogonadotropic ewe lambs manifest there is a 
decrease in both frequency and amplitude of GnRH pulses.  These results in disruption of 
high concordance between GnRH and LH pulses; small, low-amplitude pulses of GnRH 
do not produce concurrent pulses of LH [122].   
 Alternatively, GnRH may act upon GnRH neurons to stimulate GnRH release.  
Evidence for synaptic specializations between GnRH-containing terminals and GnRH 
neurons exists [123], suggesting that GnRH may modulate GnRH neuron activity.  
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Moreover, GnRH-1 receptor mRNA has been identified in subpopulations of GnRH 
neurons [124].  Therefore, it is possible that exogenous GnRH stimulates endogenous 
release of GnRH, potentially increasing the amplitude of pulses, which in turn stimulates 
the release of LH. 
 In Experiment 1, mean serum concentrations of P4 during the luteal phase 
increased in GnRH-treated mares compared to controls.  These results differ from a 
previous study in which mares were treated with continuous GnRH for 13 h in mares that 
were on days 10 to 12 after ovulation.  In that study, no differences in P4 concentrations 
were observed between GnRH-treated and control mares [9].  However, Silvia et al. [46] 
reported increases in P4 concentrations at four and eight h after a bolus injection of 2 µg 
GnRH/kg body weight on days five to six after ovulation.  In that study, similar to ours, 
mares were treated with exogenous GnRH within days five and six after ovulation when 
P4 reaches its maximum plasma concentrations [125].  Therefore, variation in days of 
treatment within the estrous cycle (early vs. late luteal phase) may explain the conflicting 
results of these experiments.  In support of these observations, the cross-sectional area of 
the CL increases from day 0 until day 7 coincident with morphological and functional 
development of the luteal tissue [126,127].  The latter is LH-dependent [128]; thus, 
increases in pulsatile LH in response to continues GnRH may have supported enhanced 
development of the corpus luteum at the time of maximal luteal growth response. 
Moreover, during the follicular phase (36 h after PGF2 administration), mean 
progesterone concentrations were higher for the GnRH treated mares than controls which 
was expected since progesterone concentrations were more elevated for this group before 
PGF2 injection.   
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  During the non-breeding season, continuous and pulsatile GnRH treatments have 
both been used to stimulate secretion of LH and, consequently, follicular development 
and ovulation [6,7,10,69]. Most of these studies have been performed after the winter 
solstice.  There is only one study in which low-dose infusion of GnRH (2.5–5.0 g/h) 
was applied before the winter solstice (October) and continued through March.  These 
low doses were unable to prevent the onset of seasonal anovulation in the fall or to 
advance the timing of ovulation in the spring, even though similar doses were previously 
shown to be effective in about 80% of persistently anovulatory mares during the natural 
breeding season [12].  We hypothesized that the different responses noted between the 
seasons is that gonadotropes may be less sensitive to GnRH stimulation in early anestrus 
compared to late anestrus (before compared to after the winter solstice).  In Experiment 2 
of the present studies, the anterior pituitary responded to continuous administration of 
GnRH at a dose of 20 g/h in December,  but not two months later, in late February.  
Previously, this dose has been used effectively during spring transition to stimulate 
secretion of LH and ovulation [6,10], but success was greater with pulsatile rather than 
continuous administration.  Becker and Johnson [6] treated anovulatory mares with either 
pulsatile or continuous GnRH  at a rate of 20 g/h during late non-breeding season.  
Mares receiving the pulsatile infusion ovulated on average 2.8 days earlier than the mares 
receiving continuous infusion even though all mares ovulated in both groups.  Although 
the equine anterior pituitary responds to continuous GnRH treatments, pulsatile 
administration still appears to provide the optimal biological signal [6,10], similar to the 
situation in other mammals.  Silvia et al. [126] provided evidence to indicate that the 
magnitude of LH release in response to a given amount of GnRH, either naturally 
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(endogenous) or induced (exogenous), is principally a function of the amount of LH 
present in the pituitary [126].  Therefore, it is likely that the amount of LH stored in the 
pituitary is greater early in anestrus than later.   Furthermore, our findings suggest that 
that the seasonal revitalization of LH production and secretion by the pituitary gland is a 
relatively slow process [126].  This is supported by the observation that when anestrous 
mares are exposed to an artificial stimulatory photoperiod, the minimum interval to first 
ovulation varies from two to three months [67,129,130].  In an earlier report [13], we 
found that the profound reduction in synthesis and secretion of anterior pituitary LH 
associated with the seasonal anovulatory period may not be due to a reduction in the 
frequency and amplitude of GnRH pulses, nor in the amount of GnRH reaching the 
anterior pituitary [13].  However, this remains a controversial finding and must be 
repeated.   If confirmed, the basis for reduced LH in the seasonally anovulatory mare may 
reside at the level of the anterior pituitary (ie, a reduced response gonadotropes to the 
GnRH signal).  Data from avian species [55,56,59,60], supported by preliminary 
information in the mare, implies that photoperiodic signals governing seasonal breeding 
are regulated, at least in part, by an inhibitory hormone, gonadotropin-inhibiting hormone 
(GnIH) that directly affects the ability of gonadotropes to respond to GnRH [unpublished 
data].  However, additional research will be required in order to determine whether and to 
what extent GnIH is involved in equine seasonality. 
   In both early and late anestrus, follicle development and estrous behavior were 
stimulated in the majority of mares only in the 100 g/h GnRH treatment (Exp 2).  
However, one mare in the GnRH-20 group showed estrous behavior, without evidence of 
an increase in circulating concentrations of LH or follicular growth, in late anestrus.   
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Unlike other ungulates, mares often exhibit estrous behavior during anestrus. .  In fact, 
even ovariectomized mares may exhibit estrous behavior [28].  Physiologically, such 
behavior may be due to stimulation by hormones of non-ovarian origin [131].  The 
adrenal cortex secretes small amounts of androgens, estrogens and progestins that might 
influence the expression of estrous behavior [131].  When ovariectomized mares were 
treated with dexamethasone, which suppresses ACTH secretion and the production of 
adrenal steroids, estrous behavior was eliminated [131].  Although numbers are low, 2/5 
mares in the GnRH-20 group exhibited estrus whereas none of 5 control mares did so, 
suggesting that this low dose was associated with an increase in estrogen production.  
However, GnRH-100 consistently increased circulating LH, folliculogenesis and 
frequency of ovulation, thus it is likely that estrous behavior in this group was associated 
with enhanced ovarian estrogen synthesis. 
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CHAPTER IV 
CONCLUSION 
 
 The equine gonadotrope continues to be GnRH-repsonsive in the presence of 
treatment with continuous high-dose GnRH during both ovulatory and anovulatory 
seasons, but it seems to be less responsive late compared to early in the anovulatory 
season.  Data herein suggest that the equine hypothalamic-gonadotropic axis is regulated 
differently than to that of other mammals, since constant infusion of GnRH did not 
disrupt the normal pattern of LH release.  Constant infusion of GnRH increases the 
frequency of LH secretory episodes during both follicular and luteal phases of the estrous 
cycle.  The mare is more responsive to contstant infusion of GnRH early in the 
anovulatory season than later. The exact mechanisms regulating seasonality at the 
hypothalamic and pituitary levels remain to be fully elucidated. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 56 
REFERENCES 
 
 
[1] Ginther OJ. Reproductive Biology of the Mare; Basic and Applied Aspects, Cross  
Plains, WI: Equiservices, 1992. 
[2] Fitzgerald BP, Schmidt MJ. Absence of an association between melatonin  
and reproductive activity in mares during the nonbreeding season. Biol Reprod  
Mono 1995;1:425-434. 
[3] Alexander SL, Irvine CHG. GnRH secretion in the mare. Anim Reprod   
 Sci.1996;42:173-180. 
[4] Cleaver BD, Grubaugh WR, Davis SD, Sheerin PC, Franklin KJ, Sharp D.C.  
 Effect of constant light exposure on circulating gonadotrophin levels and 
 hypothalamic gonadotrophin- releasing hormone (GnRH) content in the 
 ovariectomized pony mare. J Reprod Fertil Suppl 1991;44:259-66. 
[5] Malinowski K, Johnson AL, Scanes CG.  Effects of interrupted photoperiods on  
the induction of ovulation in anestrous mares. J Anim Sci 1985;61: 951-955. 
[6] Becker SE, Johnson AL. Effects of gonadotropin-releasing hormone infused in   
 a pulsatile or continuous fashion on serum gonadotropin concentrations and  
   ovulation in the mare. J Anim Sci 1992;70:1208-1215. 
[7] McCue PM, Troedsson MHT, Liu IKM, Stabenfelt GH. Follicular and  
endocrine responses of anoestrous mares to administration of native GnRH or a  
GnRH agonist. J Repro Fert Suppl 1991;44:227-233. 
[8] Hyland JH, Jeffcott LB. Control of transitional anestrus in mares.  
Theriogenology 1988;296:1383-1391. 
[9] Porter MB, Cleaver BD, Peltier M, Robinson G, Thatcher WW and Sharp DC  
 57 
Comparative study between pony and ewes evaluating gonadotrophic  
response to administration of gonadotrophin-releasing hormone. J Reprod Fertil 
1997;110, 219-229. 
[10] Johnson AL. Gonadotropin-Releasing Hormone treatment induces follicular  
growth and ovulation in seasonally anestrous mares. Biol Reprod 
1987;36:1199-1206 
[11] Williams GL, Amstalden M, Blodgett GP, Ward JE., Unnerstal DA l, Quirk KS  
Continuous administration of low-dose GnRH in mares. I. Control of persistent 
anovulation during the ovulatory season. Theriogenology 2007;68:67-75. 
[12] Collins SM, Zieba DA, Williams GL 2007 Continuous administration of low –dose  
GnRH in mares. II. Pituitary and ovarian responses to uninterrupted treatment  
beginning near the autumnal equinox and continuing throughout the anovulatory  
season. Theriogenology  68:673-681  
[13] Cooper DA, Cartmill JA, Saldarriaga JP, Zuluaga JF., Williams GL.  Seasonal  
 reproduction in mares is not regulated by changes in the frequency or amplitude  
  of GnRH pulses. Bio Reprod Special Issue 2006;166. 
[14] Reiter RJ. Evidence for refractoriness of the pituitary-gonadal axis to the pineal   
 gland in golden hamsters and its possible implication in annual reproductive   
 rhythms. Anat Rec 1972;173:365-372. 
[15] Nagy P, Guillaume D, Deals P. Seasonality in mares. Anim Reprod Sci  
 2000;60-61:245-262. 
[16] Pengelly ET, Amindson SJ. Circannual rythmicity in hibernating animals. In:   
 Pengelly ET, ed. Circannual Cloks: Annual Biological Rhythms. New York:   
 58 
 Academic Press 1974;96-160. 
[17] Thiery JC, Malpaux B. Seasonal regulation of reproductive activity in sheep.   
 Ann N.Y. Acad Sci 2003;1007:169-175. 
[18] Gallegos-Sinchez, B. Delaleu, A. Caraty, B. Malpaux,  J.C. Thiery. Estradiol acts   
 locally within the retrochiasmatic area to inhibit pulsatile luteinizing-hormone   
 release in the female sheep during anestrus. Biol Reprod 1997;56:1544-1549. 
[19] Garcia MC, Ginther OJ. Regulation of plasma LH by estradiol and progesterone in  
 ovariectomized mares. Bio Reprod 1978;19: 447-453. 
 [20] Moenter SM, Woodfill CJI, Karsch FJ.  Role of the thyroid gland in seasonal 
reproduction: thyroidectomy blocks seasonal suppression of reprodcutive 
neuroendocrine activity in ewes. Endocrinology 1991;128:1337-1344. 
[21] Thrun LA, Dahl GE, Evans NP, Karsch FJ. Effect of thyroidectomy on 
maintenance of seasonal reproductive suppression in the ewe. Biol Reprod 
1997;56:1035-1040. 
[22] Billings HJ, Viguie C, Karsch FJ, Goodman RL, Connors JM and Anderson GM. 
Temporal requirements of thyroid hormones for seasonal changes in LH 
secretion. Endocrinology 2002;143(7):2618-2625. 
[23] Hernandez JA, Hallford DM, Wells NH.  Ovarian cyclicity in thyroid suppressed   
 ewes treated with propylthiouracil immediately before onset of seasonal anestrus. 
  J Anim Sci 2003;81:29-34. 
[24] Viguie C, Battaglia DF, Krasa HB, Thrun LA, Karsch FJ.  Thyroid hormones  
 act primarily within the brain to promote the seasonal inhibition of luteinizing 
hormone secretion in the ewe. Endocrinology 1999;140:1111-1117. 
 59 
[25] Johnson AL. Serum concentrations of prolactin, thyroxine and triiodothyronine 
relative to season and the estrous cycle in the mare. J Anim Sci 1986;62:1012-  
1020. 
[26] Porter MB, Cleaver B, Robinson G, Peltier M, Shearer LC, Dahl GE, Sharp DC.   
 A comparative study examining the role of the thyroid in seasonal reproduction in 
 pony mares and ewes. Biol Reprod 1995;52,312-316. 
 [27] Medan MS, Nambo Y, Nagamine N, Shinbo H, Watanabe G, Groome N, Taya K.  
 Plasma concentrations of ir-inhibin pro-alphaC, FSH, and estradiol-17beta   
 during estrous cycle in mares and their relationship with follicular growth.
 Endocrinology 2004;1:7-14. 
[28] Sharon L, Crowell-Davis, Sexual behavior of mares. Hormo Behav 2007;52:12- 
 17. 
[29] Plotka ED, Foley CW, Witherspoon DM, Scholler GC, Goetsch DD. Periovulatory  
 changes in peripheral plasma progesterone and estrogen concentrations in the  
 mare. Amer J Vet Res 1975;36:1359-1362. 
 [30] Tetzke TA, Ismail S, Mikuckis G, Evans JW. Pattern of oxytocin secretion in   
 the mare. J Reprod Fert, Suppl. 1987;35:245-252.  
[31] McKinnon AO, Voss JL. Equine Reproduction. Media, PA: Williams and 
Wilkins; 1993. 
[32] Irvine CHG, Alexander SL, McKinnon AO. Reproductive hormone profiles in   
 mares during the autumn transition as determine by collection of  jugular blood at  
 6 h intervals throughout ovulatory and anovulatory season. J Reprod Fertil   
 2000;118:101-109. 
 60 
[33] Snyder DA, Turner DD, Miller KF, Garcia MC, Ginther OJ. Follicular and 
gonadotrophic changes during transition from ovulatory to anovulatory seasons. 
 J Reprod Fert, Suppl 1979;27:95-101. 
[34] Driancourt MA, Prunier A, Palmer E, Mariana JC. Seasonal effects on ovarian 
follicular development in pony mares. Reprod Nutr Dev 1983;23:207-215. 
[35] Freedman LJ, Garcia MC, Ginther OJ. Influence of photoperiod and ovaries on 
seasonal reproductive activity in mares. Biol Reprod 1979;20:567-574. 
[36] Fitzgerald BP, Affleck KJ, Barrows SP, Murdoch WL, Barker KB, Loy RG.  
Changes in LH pulse frequency and amplitude in intact mares during the 
transition into the breeding season. J Reprod Fert 1987;79:485-493. 
[37] Eagle RC, Tortonese DJ. Characterization and distribution of gonadotrophs in  
the pars distalis and pars tuberalis of the equine pituitary gland during the estrous 
cycle and seasonal anestrus. Biol Reprod 2000;63:826-832. 
[38] Hart PJ, Squirres EL, Imel KJ, Nett TM. Seasonal variation in  
hypothalamic content of Gonadotropin-releasing hormone (GnRH), pituitary  
receptors for GnRH, and pituitary content of luteinizing hormone and follicle-
stimulating hormone in the mare. Biol Reprod 1984;30:1055-1062. 
[39] Silvia PJ, Squires EL, Nett TM. Changes in the hypothalamic-hypophyseal  
axis of mares associated with seasonal reproductive recrudescence. Biol Reprod 
1986;35:897-905. 
[40] Silvia PJ, Johnson L, Fitzgerald BP. Changes in the hypothalamic-hypophyseal axis   
 of mares in relation to the winter solstice. J Reprod Fert 1992;96:195-202. 
 61 
[41] Lincoln GA, Johnston JD, Anderson H, Wagner G, Hazlerigg D. Photorefractoriness 
 in mammals: Dissociating a seasonal timer from the circadian-based photoperiod   
 response. Endocrinology 2005;146(9):3782-3790. 
[42] Greaves HE, Kalariotes V, Cleaver BD, Poter MB, Sharp DC.  Effects of  
 ovarian input on GnRH and LH secretion immediately postovulation in pony   
 mares.  Theriogenology 2001;55:1095-1106. 
[43] Sharp DC, Grubaugh WR. Use of push-pull perfusion techniques in studies of 
gonadotrophin-releasing hormone secretion in mares. J Reprod Fert, Suppl 
 1987;35:289-296. 
 [44] Irvine CH and Hunn R. Long term collection of pituitary venous blood in the  
unrestrained horse. NZ Med J 1984;95:735-738.  
[45] Irvine CHG, Alexander SL. A novel technique for measuring hypothalamic and   
 pituitary hormone secretion rates from collection of pituitary venous effluent in   
 the normal horse. J Endocr 1987;113:183-192. 
[46] Silvia PJ, Meyer SL, Fitzgerald BP. Pulsatile gonadotropin secretion  
determined by frequent sampling from the intercavernous sinus of the mare: 
possible modulatory role of progesterone during luteolysis. Biol Reprod. 
1995;53:438-446. 
[47] Irvine CHG, Alexander SL. Patterns of secretion of GnRH, LH and FSH  
during the postovulatory period in mares: mechanisms prolonging the LH surge. J 
Reprod Fertil 1997;109:263-271.  
[48] Strauss SS, Chen CL, Kalra SP, Sharp DC. Depletion of hypothalamic  
 62 
gonadotropin- releasing hormone (GnRH) in ovariectomized pony mares 
following melatonin implants. Fed Proc, Suppl 1978;37:225. 
[49] Vanecek J. Inhibitory effect of melatonin on GnRH-induced LH release.  
Revie Reprod 1999;4:67-72.   
[50] Fitzgerald BP, McManus CJ. Photoperiodic versus metabolic signals as 
determinants of seasonal anestrus in the mare. Biol Reprod 2000;63:335-340. 
[51] Hart PJ, Squirres EL, Imel KJ, Nett TM. Seasonal variation in hypothalamic  
content of Gonadotropin-releasing hormone (GnRH), pituitary receptors for 
GnRH, and pituitary content of luteinizing hormone and follicle-stimulating 
hormone in the mare. Biol Reprod 1984;30:1055-1062. 
[52] Silvia PJ, Squires EL, Nett TM. Changes in the hypothalamic-hypophyseal  
axis of mares associated with seasonal reproductive recrudescence. Biol 
Reprod 1986;35:897-905. 
[53] Sliwowska JH, Billings HJ, Goodman RL, Collen LM, Lehman MN. The  
premammillary hypothalamic area of the ewe: anatomical characterization of 
melatonin target area mediating seasonal reproduction. Biol Repod 2004; 
70:1768-1775. 
[54] Poulton AL, English J, Symons AM, Arendt J. Changes in plasma concentrations  
 of LH, FSH and prolactin in ewes receiving melatonin and shortphotoperiod   
 treatments to induce early onset of breeding activity. J Endocrinol 1987;112: 
 103-111. 
[55] Bentley GE, Kriegsfeld LJ, Osugi T, Ukena K, O’brien S, Perfito N, Moore IT,  
 63 
Tsutsui K and Wingfield JC.  Interaction of Gonadotropin-Releasing Hormone 
(GnRH) and Gonadotropin-Inhibitory Hormone (GnIH) in birds and mammals. J 
Experim Zoo 2006;305A:807-814. 
[56] Ikemoto T, Kyun PM. Chicken RF-amide-related peptide (GnIH) and two  
distinct receptors subtypes: identification, molecular characterization, and 
evolutionary consideration. J Reprod Develop 2005;51: 359-377. 
[57] Fukusumi S, Habata Y, Yoshida H, Iijima N, Kawamata Y, Hosoya M, Fujii R, 
Inhuma S, Kitada C, Shintani Y, Suenaga M, Onda H, Nishimura O, Tanaka M, 
Ibata Y, Fujino M. Characteristics and distribution of endogenous RFamide 
related peptide-1. Biochimica et Biophysica Acta 2001;1540:221-232. 
[58] Yoshida H, Habata Y, Hosoya M, Kawamata Y, Kitada C, Hinuma S.  
Molecular properties of endogenous RFamide-related peptide-3 and its 
interaction with receptors. Biochimica et Physica Acta 2003;1593:151-157. 
[59] Johnson MA, Tsutsui K, Fraley GS. Rat RFamide-related peptide-3 stimulates GH  
 secretion, inhibits LH secretion, and has variable affects on sex behavior in the 
  adult male rat. Hormo Behav 2007;58:171-180. 
[60] Ubuka T, Bentley GE, Ukena K, Windgfield JC and Tsutsui K. Melatonin  
induces the expression of gonadotropin-inhibitory hormone in the  
 avian brain. PNAS 2005;8(102):305-3057. 
[61] Messager S, Chatzidaki EE, Ma D, Hendrick AG, Zahn D, Dixon J, Thresher R.R,  
Malinge I, Lomet D, Carlton M. BL, Colledge WH, Caraty A. Kisspeptin directly 
stimulates gonadotropin-releasing hormone relesase vis G protein-              
            couple receptor 54. PNSA 2005;102(5):1762-1766. 
 64 
[62] Caraty A, Smith JT, Lomet D, Ben Said S, Morrissey A, Cognie J, Doughton B,  
 Baril G, Briant C, Clarke IJ. Kisspeptin synchronizes preovulatory surge in  
cyclical ewes and causes ovulation in seasonally acyclic ewes. Endocrinology 
2007;148(11):5258-5267. 
[63] Dungan HM, Gottsch ML, Zeng H, Gragerov A, Bergman JE, Vassilatis DK,  
 Clifton D K, Steiner RA. The role of Kisspeptin-GPR54 signaling in the   
 tonic regulateon and surge release of gonadotropin-releasing hormone/luteinizing 
  hormone. J Neurosci 2007;27(44):12088-12095. 
[64] Richard N, Galmiche G, Corvaisier S, Caraty A, Kottler M-L. KISS-1 and  
GPR54 genes are co-expressed in rats gonadotrophs and differentially regulate in 
vivo by oestradiol and gonadotrophin-releasing hormone. J Neuroendocrinol 
2008;20:381-393. 
[65]  Magee C, Foradori CH, Bruemmer JE, Arreguin-Arevalo JA, McCue PM, Handa 
 RJ, Squires RL, Clay CL. Biological and anatomical evidence for kisspeptin 
 regulation of the hypothalamic-pituitary-gonadal axis of estrous horse mares. 
 Endocrinology. 2009 in printing 
[66] Kooistra LH, Ginther OJ. Effect of photoperiod on reproductive activity and   
 hair in mares. Am J Vet Res 1975;36:1413-1419. 
[67] Scraba ST, Guinter OJ. Effects of lighting programs on onset of the  
ovulatory season in mares. Theriogenology 1985;24(6):667-679. 
[68] Harrison LA, Squires EL, Nett TM, McKinnon AO. Use of Gonadotropin- 
releasing hormone for hastening ovulation in transitional mares. J Anim Sci 
1990;68:690-699. 
 65 
[69] Clay CM, Squires EL. Influence of season and artificial photoperiod on  
stallions: testicular size, seminal characteristics and sexual behavior. J Anim Sci 
1987;64:517-525. 
[70] Hyland JH, Wright PJ, Clarke IJ Carson RS, Langsford DA, Jeefcott  
LB. Infusion of gonadotropin-releasing hormone (GnRH) induces ovulation and 
fertile oestrus in mares during seasonal anoestrus. J Repro Fertil Suppl 1987; 
35:211-220. 
[71] Cleaver BD, Sharp DC. Luteinizing hormone secretion in anestrous mares  
exposed to artificially lengthened photoperiod and treated with estradiol. Biol 
Reprod, Mono1995;1:449-457. 
[72] Squires EL, Moran DM, Farlin ME, Jasko DJ, Keefe TJ, Meyers SA, Figueiredo E, 
McCue PM, Jochle W. Effect of dose of GnRH analog on ovulation in mares.  
Theriogenology 1994;41:757-769. 
[73] Mumford EL, Squires EL, Peterson KD, Nett TM, Jasko DJ. Effect of various  
 doses of a gonadotropin-releasing hormone analogue on induction of ovulation in  
 anestrous mares. J Anm Sci 1994;72:178-183. 
[74] Fitzgerald BP, Meyer SL, Affleck KJ, Silvia PJ. Effect of constant 
administration of a gonadotropin-releasing hormone agonist on reproductive 
activity in mares: induction of ovulation during seasonal anestrus. Am J Vet Res 
1993;54:1735-1745. 
[75] Porter MB, Sharp DC. Gonadotropin-releasing hormone receptor trafficking  
 may explain the relative resistance to pituitary desensitization in mares. 
 Theriogenology 2002;58:523-526. 
 66 
[76] Johnson CA, McMeen SL, Thompson DL. Effects of multiple GnRH  
analogue (deslorelin acetate) implants on cyclic mares. Theriogenology 2002; 
58:469-471. 
[77] Johnson CA, Thompson DL Jr, Cartmill JA. Effects of deslorelin acetate 
 implants in horses: single implants in stallions and steroid-treated geldings and  
 multiple implants in mares. J Anim Sci 2003;(81)5:1300-1307. 
[78] Farquhar VJ, McCue PM, Carnavale EM, Nett TM, Squires EL. Deslorelin acetate  
 (Ovuplant) therapy in clycing mares: effect of implant removal on FSH 
 secretion and ovarian function.  Equi VeteriJ 2002;34:417-420. 
[79] Caraty A, Locatelli A, Delalue B, Spitz IM, Schatz B, Bouchard P. Gonadotropin- 
 releasing hormone (GnRH) agonists and GnRH antagonist do not alter 
 endogenous GnRH secretion in short-term castrated rams. Endocrinology 1990;   
 127:2523-2529. 
[80] Vickery BH, McRAE GI, Briones WV, Roberts BB, Worden AC, Schanbacher BD,  
Falvo RE.  Dose-response studies on male reproductive parameters in dogs with 
nafarelin acetate, a potetent LHRH agonist.  J Androl 1985;6:53-60. 
[81] Lacoste D, Labrie F, Dube D, Belanger A, Labrie F. Reversible inhibition of  
testicular androgen secretion by 3-, 5- and 6- months controlled release 
microsphere formulations of the LH-RH agonist [D-Trp6.des-Gly-NH102] LH-RH 
ethylamide in the dog. Steriod Biochem 1989;33:1007-1011. 
[82] Bint Akhtar F, Marshall GR, Wickings  EJ, Nieschlag E. Reversible induction   
 of azoospermia in rhesus monkeys by constant infusion of gonatotropin-releasing   
 67 
 hormone agonist using osmotic minipumps. J Clin Endocrinol & Metab 
 1983;56:543-5.40 
[83] Mann DR, Gould KG, Collins DC. Influence of continous gonadotropin- 
releasing hormone (GnRH) agonist treatment on luteinizing hormone and 
testosterone secretion. The response to GnRH , and the testicular response to 
human chorionic gonadotropin in male rhesus monkeys. J Clin Endocrinol & 
Metab 1984;58:262-267. 
[84] Labrie F, Auclair  C, Cusan L, Kelly PA, Pelletier G, Ferland L. Inhibitory effect 
  of LHRH and its agonists on testicular gonadotropin receptors and 
 spermatogenesis in the rat. Int J Androl, Suppl 1978;2:303-318. 
[85] Ward JA, Furr BJA, Valcaccia B, Curry B, Bardin CW, Gunsalus GL, Morris ID.  
Prolonged suppression of rats testis function by depot formulation of Zoladex.® a 
GnRH agonist. J Androl 1989;10:478-486. 
[86] Schurmeyer T, Knuth UA, Freischem CW, Sandow J, Akhatar FB, Nieschlag E  
 Suppression of pituitary and testicular function in normal men by constant 
 gonadotropin-releasinh hormone agonist infusion. J Clin Endocrinol & Metab  
 1984;59:19-24. 
[87] D’occhio MJ, Gifford DR, Earl CR, Weatherly T, Von Rechenberg W. Pituitary  
 and ovarian responses of post-partum acyclic beef cows to continous long-term   
 GnRH and GnRH agonist treatment. J Reprod Fertil 1989;85:495-502. 
[88] D’occhio MJ, Aspden WJ, Whyte TR. Controlled, reversiable suppression  
 of estrous cycles in beef herifers and cows using agonist of gonadotropin-
 releasing hormone.  J Anm Sci 1996;74:218-225. 
 68 
[89] Grasselli F, Barratta M, Tamanini C. Effects of a GnRH analogue  
(buserelin) infused via osmotic mini-pumps on pituitary and ovarian activity of 
prepubertal heifers. Anim Reprod Scie 1993;32;153-161. 
[90] Dodson SE, McLeod BJ, Lamming GE, Peterson AR. Ovulatory response to 
continous administration of GnRH in nine-month-old prepubertal beef heifers. 
Anim Reprod Sci 1990;22:271-280. 
 [91] Jimenez-Severino H, D’occhio MJ, Lunastra DD, Mussard ML, Koch JW, Ehnis  
 LR, Enright WJ, Kinder JE. Effects of chronic treatment with the gonadotropin-  
 releasing hormone aganost azagly-nafarelin on basal concentrations of LH   
 in prepubertal bulls. Reproduction 2003;125:225-232. 
[92] D’Occhio MJ, Aspden WJ. Characteristics of luteinizing hormone (LH) and  
 testosterone secretion, pituitary responses to LH-releasing hormone(LHRH), 
  and reproductive function in young bulls receiving the LHRH agonist 
 deslorelin: effect of castration on LH responses to LHRH. Biol Reprod 
 1996;54:45-52. 
[93] Irvine CHG., Alexander SL. Secretory pattern and rates of gonadotropin-
 releasing hormone, follicle stimulating hormone, and luteinizing hormone 
 revealed by intensive sampling of pituitary venous blood in the luteal phase.  
 Endocrinology 1993;132;(1):212-218. 
 [94] Adams TE, Horton MB, Watson JG, Adams BM. Biological activity of 
 luteinizing hormone (LH) during the estrous cycle of mares. Domest Anim  
 Endocrinol 1986;3:69–77. 
[95] Matteri RL, Papkoff H. Characterization of equine luteinizing hormone by   
 69 
 chromatofocusing. Biol Reprod 1987;36:261–269. 
[96] Shand N, Alexander SL, Irvine CH. Comparison of the microheterogeneity of  
 horse LH and FSH in the pituitary gland with that secreted intro pituitary venous  
 blood at oestrus. J Reprod Fertil, Suppl 1991;44:1–11. 
 [97] Nomura K, Ohmura K, Nakamura Y, Horiba N, Shirakura Y, Ujiharam Ohki.K,  
 Shizume K,. Porcine luteinizing hormone isoforms: relationship between their  
 molecular structures and renotropic versus gonadotropic activities. Endocrinology 
 1989;124:712–719. 
[98] Keel BA, Schanbacher BD, Grotjan HE. Ovine luteinizing hormone. I. Effects of  
 castration and steroid administration on the charge heterogeneity of pituitary  
 luteinizing hormone. Biol Reprod 1987;36:1102–1113. 
[99] Zalesky DD, Grotjan HE. Comparison of intracellular and secreted isoforms of 
  bovine and ovine luteinizing hormone. Biol Reprod 1991;44:1016–1024. 
[100] Zalesky DD, Nett TM, Grotjan HE. Ovine luteinizing hormone: isoforms in the 
  pituitary during the follicular and luteal phases of the estrous cycle and during 
  anestrus. J Anim Sci 1992;70:3851–3856. 
[101] Kojima FN, Cupp AS, Stumpf TT, Zalesky DD, Robertson MS, Werth LA,  
 Wolfe  MW, Kiuok RJ, Grotjan HE, Kinder JE. Effect of 17-estradiol on 
 distribution of pituitary isoforms of luteinizing hormone and follicle-stimulating   
 hormone during the follicular phase of the bovine estrous cycle. Biol Reprod   
 1995;52:297–304. 
[102] Perera-Mariın G, Murcia C, Rojas S, Hern´andez-Cer´on J, Gonz´alez-Padilla E,  
 Pattern of circulating luteinizing hormone isoforms during the estrous and luteal  
 70 
 phases in Holstein heifers. Anim Reprod Sci 2005;86:53–69. 
[103] Rojas-Maya S, González-Padilla E, Murcia-Mejía C, Olivares-Segura A, 
 Hernández-Cerón J, Perera-Marín G. Caprine luteinizing hormone isoforms  
 during the follicular phase and anestrus. Anim Reprod Sci 2007;100:280–290. 
[104] Krishnan KA, Proudman JA, Bahr JM. Purification and partial characterization  
 of isoforms of luteinizing hormone from chicken pituitary gland. Comp. Biochem. 
 Physiol. Biochem. Mol Biol 1994;108:253–265. 
[105] Santen RJ, Bardin CW. Episodic luteinizing hormone secretion in man: pulse  
 analysis, clinical interpretation, physiologic mechanism. J Clinic Invest  
 1973;52:2617-2628 
[106] Perera-Marin G, Murcia C, Gonzalez-Padilla E. Luteinizing hormone (LH) 
 isoforms in ruminants: characterization and physiological relevance. Anim Reprod 
 Scie 2007;101:187-207. 
[107] Levine JE, Ramirez VD. In vivo release of luteinizing hormone releasing hormone   
 estimated with push-pull cannulae from the mediobasal hypothalami of OVX,  
 steroid-primed rats. Endocrinology 1980;107:1782-1791 
[108] Moenter SM, Brand RM, Midgley AR, Karsch FJ. Dynamics of onadotrophin- 
 releasing hormone release during a pulse. Endocrinology 1992;130(1):503-510. 
[109] Nett TM, Crowder ME, Moss GE, Duello TM. GnRH receptor interaction: V  
 downregulation of pituitary receptors for GnRH in OVX ewes by infusion of  
 homologous hormone. Biol Reprod 1981,24:1145-1155. 
[110] Crowder ME, Herring RD, Nett TM. Rapid recovery of gonadotroph function after   
 downregulation of receptor for GnRH in ewes. J Reprd Fertil 1986;78:577-585. 
 71 
[111] Lincolng A. Use of a pulsed infusion of luteinizing hormone releasing hormone to 
  mimic seasonally induced endocrine changes in the ram. J Endocrinol 1979683, 
 251-260. 
[112] Witkinges J, Zaidip P, Brabangt G, Nieschlag E. Stimulation of pituitary and  
 testicular functions with LHRH agonist or pulsatile LHRH treatment on the  
 Rhesus monkey during the non-breeding season. J Reprod Fertil 1981;63:129- 
 136. 
[113] Skaggs CL, Able BV, Stevenson JS. Pulsatile or continuous infusion of 
 luteinizing hormone-releasing hormone and hormonal concentrations in   
 prepubertal beef heifers. J Anim Sci 1986;62(4):1034-48. 
[114] De Koninc J, Van Dieten JAMJ, Van Ress GP. Refractoriness of the pituitary  
 gland after continuous exposure to luteinizing hormone releasing hormone.   
 J Endocrinol 1978;79:311-318. 
 [115] Yeo T, Grossman A, Belchetz P, Besser GM. Response of luteinizing hormone  
 from columns of dispersed rat pituitary cells to a highly potent analogue of  
 luteinizing hormone releasing hormone. J Endocrinol 198191, 33-41. 
[116] Naor Z, Katikineni M,  Loumaye E, Vela AG, Dufau ML, Catt KJ. 
 Compartmentalization of luteinizing hormone pools: dynamics of gonadotrophin  
 releasing hormone action in superfused pituitary cells. Mol Cell Endocrinol  
 1982;27:213-220. 
[117] Ferland  L, Marchetti B, Seguin C, Lefebre FA, Reeves LL, Labrie F. Dissociated  
 changes of pituitary luteinizing hormone-releasing hormone (LHRH) receptors   
 and responsiveness to the neurohormone induced by 17/l-estradiol and LHRH 
 72 
  in vivo in the rat. Endocrinology 1981;109:87-93.  
[118] Garcia MC, Ginther OJ. Plasma leteinizing hormone concentrations in mares 
  treated with gonadotropin-releasing hormone and estradiol. Amer J Vet Res  
 1975;36:1581-1584 
[119] Turner JE, Irvine CHG. The effect of various gonadotrophin-releasing hormone  
 regimens on gonadotrophins, follicular growth and ovulation in deeply anoestrous 
 mares. J Reprd Fert Suppl 1991;44:213-225 
[120] Collet RA, Land RB, Baird DT. The pattern of progesterone secretion by the 
  autotransplanted ovary of the ewe in response to ovine luteinizing hormone.  
 J Endocrinol 1973;56,:403-411. 
 [121] Hsueh AJW, Dufau ML, Catt KJ. Regulation of luteinizing hormone receptors in  
 testicular interstitial cells by gonadotropin. Biochem Biophys  Resear 
 Commu 1976;72:1145-1152. 
[122] Haour F, Saez JM. HCG-dependent regulation of gonadotrophin receptor sites:  
 negative control in testicular Leydig cells. Mol Cell Endocrinol 
  1977;7:17-24.  
[123] I’anson H, Manning JM, Herbosa CG,  Pelt J, Friedman CR, Wood RI,, Bucholtz 
 DC, Foster DL. Secretion in the growth-restricted hypogonadotropic female 
 sheep. Endocrinology 2000;141:520-527. 
[124] Todman MG, Han SK, Abraham IM, Allen JP, Herbison AE. Profiling 
 neurotransmitters receptor expression in mouse GnRH neurons using GPF-
 promoter transgenic and microarrays. Neuroscience 2004;132:703-712. 
 73 
[125] Xu C, Xu XZ, Nunemaker CS, Moenter SM. Dose-dependent switch in response 
 of gonadotropin-releasing hormone (GnRH) neurons to GnRH mediated through 
 the type I GnRH receptor. Endocrinology 2004;145:728-735. 
[126] Silvia PJ,  Squirres EL, Nett TM.. Pituitary responsiveness of mares  challenged   
          with GnRH at various stages of the transition into the breeding season. J Anim Sci     
          1986;64:790-796. 
[127] Bollwein H, Mayer R, Weber F, Stolla R. Luteal blood flow during the estrous  
 cycle in mares. Theriogenology 2002;57(8):2043-51. 
[128] Ginther OJ, Utt MD, Bergfelt DR, Beg MA. Controlling interrelationships of  
 progesterone/LH and estradiol/LH in mares. Anim Reprod Sci 2006;95:144– 
 150. 
[129] Oxender WD, Noden PA, Hafs HD. Estrus, ovulation and serum progesterone,  
 estradiol and LH concentrations in mares after an increased photoperiod during  
 winter. Amer J Vet Res 1977;38:203-207. 
[130] Palmer E, Driancourt MA, Ortavant R. Photoperiodic stimulation of the mare  
 during winter anestrous. J Reprod Fertil, Suppl 1982;32:275-280.  
[131] Asa CS. Sexual behavior of mares. Vet Clin North Am Equine Pract 
 1986;2(3):519-34. 
 
 
 
 
 
 74 
APPENDIX 
 
 
PROCEDURES 
 
 
Equine LH RIA 
 
References: 
 
 Davis SL, Riechert LE, Niswender GD. Biol. Reprod. 4:415- (1971) 
 Echternkamp SE, Bolt DJ, Hawk HW.  J. Anim. Sci. 42:893- (1976) 
 Golter TD, Reeves JJ, O’Mary CC, Arimura A, Schally AV.  J. 
  Anim. Sci. 37:123- (1973) 
 Niswender GD, Riechert LE, Midgley AR, Nalbandov AV. 
  Endocrinology 84:1166- (1969) 
 Williams GL, Ray DE.  J. Anim. Sci. 50:906- (1980) 
 
 
1. Iodinated Product: Iodination grade eLH (AFP-5130A). 
 
2. Antibody: Anti-equine LH (AFP-240580). Dilution 1:120,000. 
 
3. Standards: Iodination grade eLH (AFP-5130A). Range 0.1 – 20.0 ng/ml. 
 
4. References: eLH added to equine serum 
 
5. RIA Procedure: 
 A. Day 1: Begin Assay 
  1. NSB – 500 l of 1% PBS-EW (egg white). 
  2. 0 Std – 500 l of 1% PBS-EW 
  3. Stds – 200 l std + 300 l of 1% PBS-EW. 
  4. Ref – 200 l ref + 300 l of 1% PBS-EW. 
  5. Unknown – 200 l sample + 300 l of 1% PBS-EW. 
  6. Pipette 200 l of PBS-EDTA + 1:400 NRS without primary 
    antibody into NSB tubes only. 
  7. Pipette 200 l of anti-eLH (diluted in PBS-EDTA + 1:400 NRS) 
    into all tubes except NSB and TC tubes. 
  8. Pipette 100 l 125I-eLH (20,000 cpm/100 l diluted in 1% PBS-EW) 
      to all tubes. 
  9. Vortex tubes briefly and incubate for 24 h at 4°C. 
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 B. Day 2: Add Second Antibody 
  1. Pipette 200 l of Sheep-anti-rabbit gamma globulin (SARGG; 2nd 
      Ab) diluted in PBS-EDTA without NRS into all tubes except TC 
      tubes. 
  2. Vortex tubes briefly and incubate for 48-72 h at 4°C. 
       72 
 
 
 C. Day 4: Pour Off Assay 
  1. Add 3 ml ice cold PBS (0.01 M; pH 7.0) to all test tubes except TC 
      tubes. 
  2. Centrifuge tubes for 1 h at 4°C at 3600 rpm. 
  3. Decant supernatant. 
  4. Count radioactivity of each tube using a gamma counter 
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Progesterone RIA 
 
 
Single Antibody RIA Kit, Diagnostic Products Corporation, Los Angeles, CA 
 
 
References: 
 
 Jones EJ, Armstrong JD, Harvey RW. J. Anim. Sci. 69:1607 – (1991) 
  Diagnostic Products Corporation Coat-A-Count Progesterone Kit, Los    
  Angeles, CA 
 Simpson, R.B., Armstrong, J.D. and Harvey, R.W. J. Anim. Sci. 70: 1478– 
  (1992). 
 
 
1. Iodinated Product: Iodination grade hP4. 
 
2. Antibody: Anti-human P4 coated tubes. 
3. Standards: Human serum with added P4. Range 0.1 – 20.0 ng/ml. 
 
4. Reference: Human standard preparation added to bovine serum. 
 
5. RIA Procedure: 
 
 A. Begin and complete assay 
  1. Pipette in non-coated polypropylene tubes 
    NSB – 100 l of 0 Std 
  2. Pipette in antibody coated tubes 
   0 Std – 100 l 
   Std – 100 l 
   Ref – 100 l 
   Unknowns – 100 l 
  3. Pipette 1 ml of 125I –P4 provided in the kit to all tubes including two 
      Total Count non-coated polypropylene tubes. 
  4. Vortex tubes briefly and incubate at room temperature for 3 h. 
  5. Pour off supernatant. 
  6. Count radioactivity of each tube using a gamma counter 
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